Document:

Exhibit 4.3

 

UNLESS PERMITTED UNDER SECURITIES LEGISLATION,
THE HOLDER OF THE SECURITIES REPRESENTED BY THIS WARRANT CERTIFICATE SHALL NOT TRADE SUCH SECURITIES BEFORE THE DATE THAT IS 4
MONTHS AND A DAY AFTER ●.

 

WITHOUT PRIOR WRITTEN APPROVAL OF THE
TSX VENTURE EXCHANGE AND COMPLIANCE WITH ALL APPLICABLE SECURITIES LEGISLATION, THE SECURITIES REPRESENTED BY THIS CERTIFICATE
AND THE SECURITIES ISSUABLE UPON EXERCISE OF THE SECURITIES REPRESENTED BY THIS CERTIFICATE MAY NOT BE SOLD, TRANSFERRED, HYPOTHECATED
OR OTHERWISE TRADED ON OR THROUGH THE FACILITIES OF THE TSX VENTURE EXCHANGE OR OTHERWISE IN CANADA OR TO OR FOR THE BENEFIT OF
A CANADIAN RESIDENT UNTIL ●.

 

THE SECURITIES REPRESENTED BY THIS CERTIFICATE
HAVE NOT BEEN REGISTERED UNDER THE U.S. SECURITIES ACT OF 1933, AS AMENDED (THE "SECURITIES ACT"), OR UNDER ANY STATE
SECURITIES LAWS. NEITHER THIS SECURITY NOR ANY INTEREST OR PARTICIPATION HEREIN MAY BE OFFERED, SOLD, ASSIGNED, PLEDGED, ENCUMBERED
OR OTHERWISE TRANSFERRED WITHIN THE UNITED STATES OR TO, OR FOR THE ACCOUNT OR BENEFIT OF, U.S. PERSONS IN THE ABSENCE OF SUCH
REGISTRATION UNLESS SUCH TRANSACTION IS EXEMPT FROM, OR NOT SUBJECT TO, REGISTRATION UNDER THE SECURITIES ACT, AND EXCEPT AS SET
FORTH BELOW.

 

BY ITS ACQUISITION HEREOF, THE HOLDER
AGREES THAT IT WILL NOT OFFER, RESELL OR OTHERWISE TRANSFER THIS SECURITY, EXCEPT (A) PURSUANT TO AN EFFECTIVE REGISTRATION STATEMENT
UNDER THE SECURITIES ACT, (B) TO ASSURE HOLDINGS CORP., (C) IN COMPLIANCE WITH (i) RULE 144A UNDER THE U.S. SECURITIES ACT TO
A PERSON THE SELLER REASONABLY BELIEVES TO BE A QUALIFIED INSTITUTIONAL BUYER (AS DEFINED IN RULE 144A); OR (ii) RULE 144 UNDER
THE U.S. SECURITIES ACT (“RULE 144”), IF AVAILABLE (D) OUTSIDE THE UNITED STATES IN AN OFFSHORE TRANSACTION IN COMPLIANCE
WITH REGULATION S UNDER THE SECURITIES ACT, OR (E) PURSUANT TO AN EXEMPTION FROM REGISTRATION UNDER THE SECURITIES ACT AND IN
COMPLIANCE WITH ANY APPLICABLE STATE SECURITIES LAWS.

 

FOR ANY TRANSFER PURSUANT TO REGULATION
S UNDER THE SECURITIES ACT OF THE SECURITY EVIDENCED HEREBY PRIOR TO THE RESTRICTION TERMINATION DATE, THE TRANSFEREE AGREES THAT
IT WILL DELIVER TO EACH PERSON TO WHOM THIS SECURITY IS TRANSFERRED A NOTICE SUBSTANTIALLY TO THE EFFECT OF THIS LEGEND.

 

FOR ANY TRANSFER PURSUANT TO REGULATION
S UNDER THE SECURITIES ACT OF THE SECURITY EVIDENCED HEREBY PRIOR TO THE RESTRICTION TERMINATION DATE, THE TRANSFEREE MUST MAKE
CERTAIN CERTIFICATIONS TO THE COMPANY OR TRANSFER AGENT TO CONFIRM THAT SUCH TRANSFEREE IS NOT A U.S. PERSON UNDER REGULATION
S UNDER THE SECURITIES ACT AND PROVIDE CERTAIN OTHER CERTIFICATIONS AND AGREEMENTS THAT SUCH TRANSFERS ARE BEING MADE PURSUANT
TO AN EXEMPTION FROM, OR IN A TRANSACTION NOT SUBJECT TO, THE REGISTRATION REQUIREMENTS OF THE SECURITIES ACT.

 

ADDITIONALLY, FOR ANY TRANSFER REFERRED
TO IN CLAUSE (C)(ii) or (E), OR IF REQUESTED BY ASSURE HOLDINGS CORP. OR THE TRANSFER AGENT FOR THE SECURITIES, (D), THE HOLDER
MUST, PRIOR TO SUCH TRANSFER, FURNISH TO THE COMPANY OR TRANSFER AGENT SUCH CERTIFICATIONS, LEGAL OPINIONS OR OTHER INFORMATION
AS THE COMPANY OR THE TRANSFER AGENT MAY REASONABLY REQUIRE TO CONFIRM THAT SUCH TRANSFER IS BEING MADE PURSUANT TO AN EXEMPTION
FROM OR IN A TRANSACTION NOT SUBJECT TO THE REGISTRATION REQUIREMENT OF THE SECURITIES ACT.

 

THE HOLDER HEREOF AGREES THAT IT WILL
NOT, DIRECTLY OR INDIRECTLY, ENGAGE IN ANY HEDGING TRANSACTION WITH REGARD TO THE SECURITIES EXCEPT AS PERMITTED BY THE SECURITIES
ACT.

 

     

    I 3

    

 

“RESTRICTION TERMINATION DATE”
AS USED HEREIN SHALL MEAN ONE YEAR AFTER THE LATER TO OCCUR OF THE ACQUISITION OF THE SECURITY EVIDENCED HEREBY FROM (X) ASSURE
HOLDINGS CORP. OR (Y) ANY AFFILIATE OF ASSURE HOLDINGS CORP.

 

THIS WARRANT AND THE SECURITIES DELIVERABLE
UPON EXERCISE HEREOF HAVE NOT BEEN AND WILL NOT BE REGISTERED UNDER THE UNITED STATES SECURITIES ACT OF 1933, AS AMENDED (THE
 “U.S. SECURITIES ACT”), OR THE SECURITIES LAWS OF ANY STATE OF THE UNITED STATES. THIS WARRANT MAY NOT BE EXERCISED
IN THE UNITED STATES OR BY OR ON BEHALF OF, OR FOR THE ACCOUNT OR BENEFIT OF, A U.S. PERSON UNLESS THE SECURITIES ISSUABLE UPON
EXERCISE OF THIS WARRANT HAVE BEEN REGISTERED UNDER THE U.S. SECURITIES ACT AND THE APPLICABLE SECURITIES LEGISLATION OF ANY SUCH
STATE OR AN EXEMPTION FROM SUCH REGISTRATION REQUIREMENTS IS AVAILABLE. “UNITED STATES” AND “U.S. PERSON”
ARE AS DEFINED BY REGULATION S UNDER THE U.S. SECURITIES ACT.

 

EXERCISABLE ONLY PRIOR TO 5:00 P.M. EST
ON THE EXPIRY TIME (AS HEREINAFTER DEFINED), AFTER WHICH TIME THESE WARRANTS SHALL BE NULL AND VOID.

 

WARRANTS TO PURCHASE

COMMON SHARES
OF ASSURE HOLDINGS CORP.

 

	Warrant Certificate Number:	Number of Warrants:
	 	 
	WC-US-2020-00●	●
	 	 

THIS IS TO CERTIFY THAT for value
received ● (the "Warrantholder"), at ● has the right to purchase in respect of each warrant
("Warrants") represented by this certificate or by a replacement certificate (in either case this
 "Warrant Certificate"), at any time up to 5:00 p.m. (Eastern Standard Time), on the______ day of ●
(the "Expiry Time") one fully paid and non-assessable common share ("Common Shares" and
which term shall include any shares or other securities to be issued in addition thereto or in substitution or replacement
therefor as provided herein) of Assure Holdings Corp. (the "Corporation"), a corporation existing under the
laws of the State of Nevada, as constituted on the date hereof at a purchase price (the purchase price in effect from time to
time being called the "Exercise Price") of US$● per Common Share, subject to adjustment as provided
herein.

 

The Corporation agrees that the Common
Shares purchased pursuant to the exercise of the Warrants shall be and be deemed to be issued to the Warrantholder as of the close
of business on the date on which this Warrant Certificate shall have been surrendered and payment made for such Common Shares
as aforesaid.

 

Nothing contained herein shall confer
any right upon the Warrantholder to subscribe for or purchase any Common Shares at any time after the Expiry Time and, from and
after the Expiry Time, the Warrants and all rights under this Warrant Certificate shall be null and void and of no value.

 

The above provisions are subject to the following:

 

1.             Exercise:

 

(1)          
Cash Exercise: In the event that the Warrantholder desires to exercise the right to purchase Common Shares
conferred hereby, the Warrantholder shall (a) complete to the extent possible in the manner indicated and execute a subscription
form in the form attached as Schedule A to this Warrant Certificate, (b) surrender this Warrant Certificate to the Corporation
in accordance with section 9 hereof, and (c) pay the amount payable on the exercise of such Warrants in respect of the Common
Shares subscribed for by certified cheque, bank draft or money order in lawful money of the United States of America payable to
the Corporation or by transmitting same day funds in lawful money of the United States of America by wire to such account as the
Corporation shall direct the Warrantholder. Upon such surrender and payment as aforesaid, the Warrantholder shall be deemed for
all purposes to be the holder of record of the number of Common Shares to be so issued and the Warrantholder shall be entitled
to delivery of a certificate or certificates representing such Common Shares and the Corporation shall cause such certificate
or certificates to be delivered to the Warrantholder at the address specified in the subscription form within ten business days
after such surrender and payment as aforesaid. No fractional Common Shares will be issuable upon any exercise of the Warrants
and the Warrantholder will not be entitled to any cash payment or compensation in lieu of a fractional Common Share.

 

     

    I 4

    

 

(2)          
US Persons: Notwithstanding any provision in sections 1, 2 or 3 hereof, the Warrants may not be exercised, in whole
or in part, by a U.S. Person or person within the United States (or on behalf of a U.S. Person or person within the United States)
unless registered under the United States Securities Act of 1933, as amended (the "1933 Act") and applicable
state securities laws or unless an exemption from such registration is available. As used herein, the terms "United States"
and "U.S. Person" have the meaning assigned to them in Regulation S under the 1933 Act.

 

2.          
Partial Exercise: The Warrantholder may from time to time subscribe for and purchase any lesser number of
Common Shares than the number of Common Shares expressed in this Warrant Certificate. In the event that the Warrantholder subscribes
for and purchases any such lesser number of Common Shares prior to the Expiry Time, the Warrantholder shall be entitled to receive
a replacement certificate representing the unexercised balance of the Warrants.

 

3.           
Not a Shareholder: The holding of the Warrants shall not constitute the Warrantholder a shareholder of the
Corporation nor entitle the Warrantholder to any right or interest in respect thereof except as expressly provided in this Warrant
Certificate.

 

4.           
Covenants, Representations and Warranties: The Corporation hereby represents and warrants that it is authorized
to create and issue the Warrants and covenants and agrees that it will cause the Common Shares from time to time subscribed for
and purchased in the manner provided in this Warrant Certificate and the certificate or certificates representing such Common
Shares to be issued and that, at all times prior to the Expiry Time, it will reserve and there will remain unissued a sufficient
number of Common Shares to satisfy the right of purchase provided for in this Warrant Certificate. The Corporation hereby further
covenants and agrees that it will at its expense expeditiously use its best efforts to obtain the listing of such Common Shares
(subject to issue or notice of issue) on each stock exchange or over-the-counter market on which the Common Shares may be listed
from time to time. All Common Shares which are issued upon the exercise of the right of purchase provided in this Warrant Certificate,
upon payment therefor of the amount at which such Common Shares may be purchased pursuant to the provisions of this Warrant Certificate,
shall be and be deemed to be fully paid and non-assessable shares and free from all taxes, liens and charges with respect to the
issue thereof. The Corporation hereby represents and warrants that this Warrant Certificate is a valid and enforceable obligation
of the Corporation, enforceable in accordance with the provisions of this Warrant Certificate.

 

     

    I 5

    

 

5.            
Anti-Dilution Protection:

 

		(1)	Definitions: For the purposes
                                         of this section 5, unless there is something in the subject matter or context inconsistent
                                         therewith, the words and terms defined below shall have the respective meanings specified
                                         therefor in this subsection 5(1):

 

(a)          
"Adjustment Period" means the period commencing on the date of issue of the Warrants and ending at the Expiry
Time;

 

(b)         
"Current Market Price" of the Common Shares at any date means the price per share equal to the volume weighted
average price at which the Common Shares have traded on the TSX Venture Exchange (the “TSXV”) or, if the Common
Shares are not then listed on the TSXV, on such other Canadian stock exchange as may be selected by the directors of the Corporation
for such purpose or, if the Common Shares are not then listed on any Canadian stock exchange, in the over-the-counter market,
during the period of any twenty (20) consecutive trading days ending not more than five (5) trading days before such date; provided
that the volume weighted average price shall be determined by dividing the aggregate sale price of all Common Shares sold on the
said exchange or market, as the case may be, during such twenty (20) consecutive trading days by the total number of Common Shares
so sold; and provided further that if the Common Shares are not then listed on any Canadian stock exchange or traded in the over-the-counter
market, then the Current Market Price shall be determined by a firm of independent chartered accountants selected by the directors
of the Corporation;

 

(c)          
"director" means a director of the Corporation for the time being and, unless otherwise specified herein, a reference
to action "by the directors" means action by the directors of the Corporation as a board or, whenever empowered, action
by any committee of the directors of the Corporation; and

 

(d)          
"trading day" with respect to a stock exchange or over-the-counter market means a day on which such stock exchange
or market is open for business.

 

		(2)	Adjustments: The Exercise
                                         Price and the number of Common Shares issuable to the Warrantholder upon the exercise
                                         of the Warrants shall be subject to adjustment from time to time in the events and in
                                         the manner provided as follows:

 

(a)          
If at any time during the Adjustment Period the Corporation shall:

 

		(i)	fix a record date for the issue
                                         of, or issue, Common Shares to the holders of all or substantially all of the outstanding
                                         Common Shares by way of a stock dividend;

 

		(ii)	fix a record
                                         date for the distribution to, or make a distribution to, the holders of all or substantially
                                         all of the outstanding Common Shares payable in Common Shares or securities exchangeable
                                         for or convertible into Common Shares;

 

		(iii)	subdivide the
                                         outstanding Common Shares into a greater number of Common Shares; or

 

     

    I 6

    

 

		(iv)	consolidate
                                         the outstanding Common Shares into a lesser number of Common Shares,
	 	 	 
	 	(any of such events in subclauses 5(2)(a)(i), 5(2)(a)(ii), 5(2)(a)(iii)
               and 5(2)(a)(iv) above being herein called a "Common Share Reorganization"), the Exercise Price
               shall be adjusted on the earlier of the record date on which holders of Common Shares are determined for the purposes
               of the Common Share Reorganization and the effective date of the Common Share Reorganization to the amount determined
               by multiplying the Exercise Price in effect immediately prior to such record date or effective date, as the case
               may be, by a fraction:

 

		A.	the numerator of which shall be
                                         the number of Common Shares outstanding on such record date or effective date, as the
                                         case may be, before giving effect to such Common Share Reorganization; and

 

		B.	the denominator of which shall
                                         be the number of Common Shares which will be outstanding immediately after giving effect
                                         to such Common Share Reorganization (including in the case of a distribution of securities
                                         exchangeable for or convertible into Common Shares the number of Common Shares that would
                                         have been outstanding had such securities been exchanged for or converted into Common
                                         Shares on such date).

 

To the extent that any adjustment
in the Exercise Price occurs pursuant to this clause 5(2)(a) as a result of the fixing by the Corporation of a record date for
the distribution of securities exchangeable for or convertible into Common Shares, the Exercise Price shall be readjusted immediately
after the expiry of any relevant exchange or conversion right to the Exercise Price which would then be in effect based upon the
number of Common Shares actually issued and remaining issuable after such expiry and shall be further readjusted in such manner
upon the expiry of any further such right. Any Warrantholder who has not exercised his right to subscribe for and purchase Common
Shares on or prior to the record date of such stock dividend or distribution or the effective date of such subdivision or consolidation,
as the case may be, upon the exercise of such right thereafter shall be entitled to receive and shall accept in lieu of the number
of Common Shares then subscribed for and purchased by such Warrantholder, at the Exercise Price determined in accordance with
this clause 5(2)(a) the aggregate number of Common Shares that such Warrantholder would have been entitled to receive as a result
of such Common Share Reorganization, if, on such record date or effective date, as the case may be, such Warrantholder had been
the holder of record of the number of Common Shares so subscribed for and purchased.

 

(b)          
If at any time during the Adjustment Period the Corporation shall fix a record date for the issue or distribution to the
holders of all or substantially all of the outstanding Common Shares of rights, options or warrants pursuant to which such holders
are entitled, during a period expiring not more than 45 days after the record date for such issue (such period being the "Rights
Period"), to subscribe for or purchase Common Shares or securities exchangeable for or convertible into Common Shares
at a price per share to the holder (or in the case of securities exchangeable for or convertible into Common Shares, at an exchange
or conversion price per share) at the date of issue of such securities of less than 95% of the Current Market Price of the Common
Shares on such record date (any of such events being called a "Rights Offering"), the Exercise Price shall be
adjusted effective immediately after the record date for such Rights Offering to the amount determined by multiplying the Exercise
Price in effect on such record date by a fraction:

 

     

    I 7

    

 

(i)            
the numerator of which shall be the aggregate of

 

A.           
the number of Common Shares outstanding on the record date for the Rights Offering, and

 

B.           
the quotient determined by dividing

 

(1)           either
(a) the product of the number of Common Shares offered during the Rights Period pursuant to the Rights Offering and the price
at which such Common Shares are offered, or, (b) the product of the exchange or conversion price of the securities so offered
and the number of Common Shares for or into which the securities offered pursuant to the Rights Offering may be exchanged or converted,
as the case may be, by

 

(2)           
the Current Market Price of the Common Shares as of the record date for the Rights Offering; and

 

(ii)          
the denominator of which shall be the aggregate of the number of Common Shares outstanding on such record date and the
number of Common Shares offered pursuant to the Rights Offering (including in the case of the issue or distribution of securities
exchangeable for or convertible into Common Shares the number of Common Shares for or into which such securities may be exchanged
or converted).

 

If by the terms of the rights,
options, or warrants referred to in this clause 5(2)(b), there is more than one purchase, conversion or exchange price per Common
Share, the aggregate price of the total number of additional Common Shares offered for subscription or purchase, or the aggregate
conversion or exchange price of the convertible or exchangeable securities so offered, shall be calculated for purposes of the
adjustment on the basis of the lowest purchase, conversion or exchange price per Common Share, as the case may be. Any Common
Shares owned by or held for the account of the Corporation shall be deemed not to be outstanding for the purpose of any such calculation.
To the extent that any adjustment in the Exercise Price occurs pursuant to this clause 5(2)(b) as a result of the fixing by the
Corporation of a record date for the issue or distribution of rights, options or warrants referred to in this clause 5(2)(b),
the Exercise Price shall be readjusted immediately after the expiry of any relevant exchange, conversion or exercise right to
the Exercise Price which would then be in effect based upon the number of Common Shares actually issued and remaining issuable
after such expiry and shall be further readjusted in such manner upon the expiry of any further such right.

 

     

    I 8

    

 

(c)          
If at any time during the Adjustment Period the Corporation shall fix a record date for the issue or distribution to the
holders of all or substantially all of the outstanding Common Shares of:

 

(i)           shares
of the Corporation of any class other than Common Shares;

 

(ii)          rights,
options or warrants to acquire Common Shares or securities exchangeable for or convertible into Common Shares (other than rights,
options or warrants pursuant to which holders of Common Shares are entitled, during a period expiring not more than 45 days after
the record date for such issue, to subscribe for or purchase Common Shares or securities exchangeable for or convertible into
Common Shares at a price per share (or in the case of securities exchangeable for or convertible into Common Shares at an exchange
or conversion price per share) at the date of issue of such securities to the holder of at least 95% of the Current Market Price
of the Common Shares on such record date);

 

(iii)        
evidences of indebtedness of the Corporation; or

 

(iv)        
any property or assets of the Corporation;

 

and if such issue or distribution
does not constitute a Common Share Reorganization or a Rights Offering (any of such non-excluded events being herein called a
 "Special Distribution "), the Exercise Price shall be adjusted effective immediately after the record date for
the Special Distribution to the amount determined by multiplying the Exercise Price in effect on the record date for the Special
Distribution by a fraction:

 

A.           
the numerator of which shall be the difference between

 

		(1)	the product of
                                         the number of Common Shares outstanding on such record date and the Current Market Price
                                         of the Common Shares on such record date, and

 

		(2)	the fair value,
                                         as determined by the directors of the Corporation, to the holders of Common Shares of
                                         the shares, rights, options, warrants, evidences of indebtedness or property or assets
                                         to be issued or distributed in the Special Distribution, and

 

B.           
the denominator of which shall be the product obtained by multiplying the number of Common Shares outstanding on such record
date by the Current Market Price of the Common Shares on such record date.

 

Any Common Shares owned by or
held for the account of the Corporation shall be deemed not to be outstanding for the purpose of such calculation. To the extent
that any adjustment in the Exercise Price occurs pursuant to this clause 5(2)(c) as a result of the fixing by the Corporation
of a record date for the issue or distribution of rights, options or warrants to acquire Common Shares or securities exchangeable
for or convertible into Common Shares referred to in this clause 5(2)(c), the Exercise Price shall be readjusted immediately after
the expiry of any relevant exercise, exchange or conversion right to the amount which would then be in effect based upon the number
of Common Shares issued and remaining issuable after such expiry and shall be further readjusted in such manner upon the expiry
of any further such right.

 

     

    I 9

    

 

 

(d)          
If at any time during the Adjustment Period there shall occur:

 

(i)          
a reclassification or redesignation of the Common Shares, a change of the Common Shares into other shares or securities
or any other capital reorganization involving the Common Shares other than a Common Share Reorganization;

 

(ii)        
a consolidation, amalgamation or merger of the Corporation with or into another body corporate which results in a reclassification
or redesignation of the Common Shares or a change of the Common Shares into other shares or securities;

 

(iii)        
the transfer of the undertaking or assets of the Corporation as an entirety or substantially as an entirety to another
corporation or entity;

 

(any of such events being called
a "Capital Reorganization"), after the effective date of the Capital Reorganization the Warrantholder shall be
entitled to receive, and shall accept, for the same aggregate consideration, upon exercise of the Warrants, in lieu of the number
of Common Shares to which the Warrantholder was theretofore entitled upon the exercise of the Warrants, the kind and aggregate
number of shares and other securities or property resulting from the Capital Reorganization which the Warrantholder would have
been entitled to receive as a result of the Capital Reorganization if, on the effective date thereof, the Warrantholder had been
the registered holder of the number of Common Shares which the Warrantholder was theretofore entitled to purchase or receive upon
the exercise of the Warrants. If necessary, as a result of any such Capital Reorganization, appropriate adjustments shall be made
in the application of the provisions of this Warrant Certificate with respect to the rights and interests thereafter of the Warrantholder
to the end that the provisions shall thereafter correspondingly be made applicable as nearly as may reasonably be possible in
relation to any shares or other securities or property thereafter deliverable upon the exercise of the Warrants.

 

(e)          
If at any time during the Adjustment Period any adjustment or readjustment in the Exercise Price shall occur pursuant to
the provisions of clause 5(2)(a), 5(2)(b) or 5(2)(c) of this Warrant Certificate, then the number of Common Shares purchasable
upon the subsequent exercise of the Warrants shall be simultaneously adjusted or readjusted, as the case may be, by multiplying
the number of Common Shares purchasable upon the exercise of the Warrants immediately prior to such adjustment or readjustment
by a fraction which shall be the reciprocal of the fraction used in the adjustment or readjustment of the Exercise Price.

 

     

    I 10

    

 

(3)           
Rules: The following rules and procedures shall be applicable to adjustments made pursuant to subsection 5(2) hereof:

 

(a)         
Subject to the following clauses of this subsection 5(3), any adjustment made pursuant to subsection 5(2) hereof shall
be made successively whenever an event referred to therein shall occur.

 

(b)         
No adjustment in the Exercise Price shall be required unless such adjustment would result in a change of at least one per
cent in the then Exercise Price and no adjustment shall be made in the number of Common Shares purchasable or issuable on the
exercise of the Warrants unless it would result in a change of at least one one-hundredth of a Common Share; provided, however,
that any adjustments which except for the provision of this clause 5(3)(b) would otherwise have been required to be made shall
be carried forward and taken into account in any subsequent adjustment. Notwithstanding any other provision of subsection 5(2)
hereof, no adjustment of the Exercise Price shall be made which would result in an increase in the Exercise Price or a decrease
in the number of Common Shares issuable upon the exercise of the Warrants (except in respect of the Common Share Reorganization
described in subclause 5(2)(a)(iv) hereof or a Capital Reorganization described in subclause 5(2)(d)(ii) hereof).

 

(c)         
No adjustment in the Exercise Price or in the number or kind of securities purchasable upon the exercise of the Warrants
shall be made in respect of any event described in section 5 hereof if the Warrantholder is entitled to participate in such event
on the same terms mutatis mutandis as if the Warrantholder had exercised the Warrants prior to or on the record date or
effective date, as the case may be, of such event.

 

(d)         
No adjustment in the Exercise Price or in the number of Common Shares purchasable upon the exercise of the Warrants shall
be made pursuant to subsection 5(2) hereof in respect of the issue from time to time of Common Shares pursuant to this Warrant
Certificate or pursuant to any stock option, stock purchase or stock bonus plan in effect from time to time for directors, officers
or employees of the Corporation and/or any subsidiary of the Corporation and any such issue, and any grant of options in connection
therewith, shall be deemed not to be a Common Share Reorganization, a Rights Offering nor any other event described in subsection
5(2) hereof.

 

(e)         
If at any time during the Adjustment Period the Corporation shall take any action affecting the Common Shares, other than
an action described in subsection 5(2) hereof, which in the opinion of the directors would have a material adverse effect upon
the rights of Warrantholders, either or both the Exercise Price and the number of Common Shares purchasable upon exercise of Warrants
shall be adjusted in such manner and at such time by action by the directors, in their sole discretion, as may be equitable in
the circumstances. Failure of the taking of action by the directors so as to provide for an adjustment prior to the effective
date of any action by the Corporation affecting the Common Shares shall be deemed to be conclusive evidence that the directors
have determined that it is equitable to make no adjustment in the circumstances.

 

     

    I 11

    

 

(f)          
If the Corporation shall set a record date to determine holders of Common Shares for the purpose of entitling such holders
to receive any dividend or distribution or any subscription or purchase rights and shall, thereafter and before the distribution
to such holders of any such dividend, distribution or subscription or purchase rights, legally abandon its plan to pay or deliver
such dividend, distribution or subscription or purchase rights, then no adjustment in the Exercise Price or the number of Common
Shares purchasable upon exercise of the Warrant shall be required by reason of the setting of such record date.

 

(g)         
In any case in which this Warrant Certificate shall require that an adjustment shall become effective immediately after
a record date for an event referred to in subsection 5(2) hereof, the Corporation may defer, until the occurrence of such event:

 

(i)          
issuing to the Warrantholder, to the extent that the Warrants are exercised after such record date and before the occurrence
of such event, the additional Common Shares or other securities issuable upon such exercise by reason of the adjustment required
by such event; and

 

(ii)        
delivering to the Warrantholder any distribution declared with respect to such additional Common Shares or other securities
after such record date and before such event;

 

provided, however, that the
Corporation shall deliver to the Warrantholder an appropriate instrument evidencing the right of the Warrantholder upon the occurrence
of the event requiring the adjustment, to an adjustment in the Exercise Price or the number of Common Shares purchasable upon
the exercise of the Warrants and to such distribution declared with respect to any such additional Common Shares issuable on the
exercise of the Warrants.

 

(h)         
In the absence of a resolution of the directors fixing a record date for a Rights Offering, the Corporation shall be deemed
to have fixed as the record date therefor the date of the issue of the rights, options or warrants issued pursuant to the Rights
Offering.

 

(i)          
If a dispute shall at any time arise with respect to adjustments of the Exercise Price or the number of Common Shares purchasable
upon the exercise of the Warrants, such disputes shall be conclusively determined by the auditors of the Corporation or if they
are unable or unwilling to act, by such other firm of independent chartered accountants as may be selected by the directors and
any such determination shall be conclusive evidence of the correctness of any adjustment made pursuant to subsection 5(2) hereof
and shall be binding upon the Corporation and the Warrantholder.

 

(j)          
As a condition precedent to the taking of any action which would require an adjustment pursuant to subsection 5(2) hereof,
including the Exercise Price and the number or class of Common Shares or other securities which are to be received upon the exercise
thereof, the Corporation shall take any action which may, in the opinion of counsel to the Corporation, be necessary in order
that the Corporation may validly and legally issue as fully paid and non-assessable shares all of the Common Shares or other securities
which the Warrantholder is entitled to receive in accordance with the provisions of this Warrant Certificate.

 

     

    I 12

    

 

(4)         
Notice: At least 21 days prior to the earlier of the record date or effective date of any event which requires or
might require an adjustment in any of the rights of the Warrantholder under this Warrant Certificate, including the Exercise Price
or the number of Common Shares which may be purchased under this Warrant Certificate, the Corporation shall deliver to the Warrantholder
a certificate of the Corporation specifying the particulars of such event and, if determinable, the required adjustment and the
calculation of such adjustment. In case any adjustment for which a notice in this subsection 5(4) has been given is not then determinable,
the Corporation shall promptly after such adjustment is determinable deliver to the Warrantholder a certificate providing the
calculation of such adjustment. The Corporation hereby covenants and agrees that the register of transfers and share transfer
books for the Common Shares will be open, and that the Corporation will not take any action which might deprive the Warrantholder
of the opportunity of exercising the rights of subscription contained in this Warrant Certificate, during such 21 day period.

 

6.          
Further Assurances: The Corporation hereby covenants and agrees that it will do, execute, acknowledge and
deliver, or cause to be done, executed, acknowledged and delivered, all and every such other act, deed and assurance as the Warrantholder
shall reasonably require for the better accomplishing and effectuating of the intentions and provisions of this Warrant Certificate.

 

7.           
Time of Essence: Time shall be of the essence of this Warrant Certificate.

 

8.          
Governing Laws: This Warrant Certificate shall be construed in accordance with the laws of the Province of
Ontario and the federal laws of Canada applicable therein.

 

9.          
Notices: All notices or other communications to be given under this Warrant Certificate shall be delivered
by hand or by recorded electronic communication and, if delivered by hand, shall be deemed to have been given on the delivery
date and, if sent by recorded electronic communication, on the date of transmission if sent before 5:00 p.m. on a business day
or, if such day is not a business day, on the first business day following the date of transmission.

 

Notices to the Corporation shall be addressed to:

 

Assure Holdings Corp.

4600 South Ulster Street

Denver, Colorado 80237 Attention: John Farlinger,
CEO

Email: john.farlinger@assureiom.com

 

Notices to the Warrantholder shall be addressed to
the address of the Warrantholder set out on page 2 of this Warrant Certificate.

 

The Corporation and the Warrantholder may change
its address for service by notice in writing to the other of them specifying its new address for service under this Warrant Certificate.

 

     

    I 13

    

 

10.         Legend
on Common Shares:

 

Any certificate representing Common Shares issued
upon the exercise of the Warrants prior to the date which is four months and one day after the date hereof will bear the following
legends:

 

"UNLESS PERMITTED UNDER SECURITIES
LEGISLATION, THE HOLDER OF THE SECURITIES REPRESENTED BY THIS CERTIFICATE SHALL NOT TRADE THE SECURITIES BEFORE THE DATE THAT
IS 4 MONTHS AND A DAY AFTER ●, 2020.

 

WITHOUT PRIOR WRITTEN APPROVAL
OF THE TSX VENTURE EXCHANGE AND COMPLIANCE WITH ALL APPLICABLE SECURITIES LEGISLATION, THE SECURITIES REPRESENTED BY THIS CERTIFICATE
MAY NOT BE SOLD, TRANSFERRED, HYPOTHECATED OR OTHERWISE TRADED ON OR THROUGH THE FACILITIES OF THE TSX VENTURE EXCHANGE OR OTHERWISE
IN CANADA OR TO OR FOR THE BENEFIT OF A CANADIAN RESIDENT UNTIL ●."

 

provided that at any time subsequent
to the date which is four months and one day after the date hereof any certificate representing such Common Shares may be exchanged
for a certificate bearing no such legend. The Corporation shall use the best efforts thereof to cause the registrar and transfer
agent to deliver the certificate representing such Common Shares within ten (10) business days after receipt of the legended certificate
or certificates.

 

In addition to the foregoing,
any certificate representing Common Shares issued upon exercise of the Warrants will bear the following legends for the one-year
distribution compliance period, for non-U.S. Subscribers, or the restricted period, for U.S. Subscribers:

 

“THE BENEFIT OF A CANADIAN RESIDENT UNTIL ●.

 

“THE SECURITIES REPRESENTED
BY THIS CERTIFICATE HAVE NOT BEEN REGISTERED UNDER THE U.S. SECURITIES ACT OF 1933, AS AMENDED (THE "SECURITIES ACT"),
OR UNDER ANY STATE SECURITIES LAWS. NEITHER THIS SECURITY NOR ANY INTEREST OR PARTICIPATION HEREIN MAY BE OFFERED, SOLD, ASSIGNED,
PLEDGED, ENCUMBERED OR OTHERWISE TRANSFERRED WITHIN THE UNITED STATES OR TO, OR FOR THE ACCOUNT OR BENEFIT OF, U.S. PERSONS IN
THE ABSENCE OF SUCH REGISTRATION UNLESS SUCH TRANSACTION IS EXEMPT FROM, OR NOT SUBJECT TO, REGISTRATION UNDER THE SECURITIES
ACT, AND EXCEPT AS SET FORTH BELOW.

 

BY ITS ACQUISITION HEREOF, THE
HOLDER AGREES THAT IT WILL NOT OFFER, RESELL OR OTHERWISE TRANSFER THIS SECURITY, EXCEPT (A) PURSUANT TO AN EFFECTIVE REGISTRATION
STATEMENT UNDER THE SECURITIES ACT, (B) TO ASSURE HOLDINGS CORP., (C) IN COMPLIANCE WITH (i) RULE 144A UNDER THE U.S. SECURITIES
ACT TO A PERSON THE SELLER REASONABLY BELIEVES TO BE A QUALIFIED INSTITUTIONAL BUYER (AS DEFINED IN RULE 144A); OR (ii) RULE 144
UNDER THE U.S. SECURITIES ACT (“RULE 144”), IF AVAILABLE (D) OUTSIDE THE UNITED STATES IN AN OFFSHORE TRANSACTION
IN COMPLIANCE WITH REGULATION S UNDER THE SECURITIES ACT, OR (E) PURSUANT TO AN EXEMPTION FROM REGISTRATION UNDER THE SECURITIES
ACT AND IN COMPLIANCE WITH ANY APPLICABLE STATE SECURITIES LAWS.

 

     

    I 14

    

 

FOR ANY TRANSFER PURSUANT TO
REGULATION S UNDER THE SECURITIES ACT OF THE SECURITY EVIDENCED HEREBY PRIOR TO THE RESTRICTION TERMINATION DATE, THE TRANSFEREE
AGREES THAT IT WILL DELIVER TO EACH PERSON TO WHOM THIS SECURITY IS TRANSFERRED A NOTICE SUBSTANTIALLY TO THE EFFECT OF THIS LEGEND.

 

FOR ANY TRANSFER PURSUANT TO
REGULATION S UNDER THE SECURITIES ACT OF THE SECURITY EVIDENCED HEREBY PRIOR TO THE RESTRICTION TERMINATION DATE, THE TRANSFEREE
MUST MAKE CERTAIN CERTIFICATIONS TO THE COMPANY OR TRANSFER AGENT TO CONFIRM THAT SUCH TRANSFEREE IS NOT A U.S. PERSON UNDER REGULATION
S UNDER THE SECURITIES ACT AND PROVIDE CERTAIN OTHER CERTIFICATIONS AND AGREEMENTS THAT SUCH TRANSFERS ARE BEING MADE PURSUANT
TO AN EXEMPTION FROM, OR IN A TRANSACTION NOT SUBJECT TO, THE REGISTRATION REQUIREMENTS OF THE SECURITIES ACT.

 

ADDITIONALLY, FOR ANY TRANSFER
REFERRED TO IN CLAUSE (C)(ii) or (E), OR IF REQUESTED BY ASSURE HOLDINGS CORP. OR THE TRANSFER AGENT FOR THE SECURITIES, (D),
THE HOLDER MUST, PRIOR TO SUCH TRANSFER, FURNISH TO THE COMPANY OR TRANSFER AGENT SUCH CERTIFICATIONS, LEGAL OPINIONS OR OTHER
INFORMATION AS THE COMPANY OR THE TRANSFER AGENT MAY REASONABLY REQUIRE TO CONFIRM THAT SUCH TRANSFER IS BEING MADE PURSUANT TO
AN EXEMPTION FROM OR IN A TRANSACTION NOT SUBJECT TO THE REGISTRATION REQUIREMENT OF THE SECURITIES ACT.

 

THE HOLDER HEREOF AGREES THAT
IT WILL NOT, DIRECTLY OR INDIRECTLY, ENGAGE IN ANY HEDGING TRANSACTION WITH REGARD TO THE SECURITIES EXCEPT AS PERMITTED BY THE
SECURITIES ACT.

 

“RESTRICTION TERMINATION
DATE” AS USED HEREIN SHALL MEAN ONE YEAR AFTER THE LATER TO OCCUR OF THE ACQUISITION OF THE SECURITY EVIDENCED HEREBY FROM
(X) ASSURE HOLDINGS CORP. OR (Y)  ANY AFFILIATE OF ASSURE HOLDINGS CORP.”

 

11.        
Lost Certificate: If this Warrant Certificate or any replacement hereof becomes stolen, lost, mutilated or
destroyed, the Corporation shall, on such terms as it may in its discretion impose, acting reasonably, issue and deliver a new
certificate, in form identical hereto but with appropriate changes, representing any unexercised portion of the subscription rights
represented hereby to replace the certificate so stolen, lost, mutilated or destroyed.

 

12.        
Language: The parties hereto acknowledge and confirm that they have requested that this Warrant Certificate
as well as all notices and other documents contemplated hereby be drawn up in the English language. Les parties aux présentes
reconnaissent et confirment qu'elles ont exigé que la présente convention ainsi que tous les avis et documents qui
s'y rattachent soient rédigés en langue anglaise.

 

     

    I 15

    

 

13.        
Transfer: The Warrants are transferable in accordance with the restrictions contained herein including any
restrictive legends on this Warrant Certificate, and the term "Warrantholder" shall mean and include any successor,
transferee or assignee of the current or any future Warrantholder. The Warrants may be transferred by the Warrantholder completing
and delivering to the Corporation the transfer form attached hereto as Schedule B.

 

14.        
Successors and Assigns: This Warrant Certificate shall enure to the benefit of the Warrantholder and the
successors and assignees thereof and shall be binding upon the Corporation and the successors thereof.

 

     

    I 16

    

 

IN WITNESS WHEREOF the Corporation has
caused this Warrant Certificate to be signed by an authorized officer as of the _____ day of _____________, 20____.

 

	 	ASSURE HOLDINGS CORP.
	 	 	 
	 	Per:	 
	 	 	Authorized Signing Officer

 

     

    I 17

    

 

SCHEDULE A

 

SUBSCRIPTION
FORM

 

TO:ASSURE HOLDINGS
CORP.

 

The undersigned hereby:

 

1.           
subscribes for _______________ common shares ("Common Shares") of Assure Holdings Corp. (the "Corporation")
(or such other number of common shares or other securities to which such subscription entitles the undersigned in lieu thereof
or in addition thereto pursuant to the provisions of the warrant certificate (the "Warrant Certificate") dated
the _____ day of _______________, 2020 (the “Issuance Date”) issued by the Corporation) at the purchase price
of US$1.00 per Common Share (or at such other purchase price as may be in effect under the provisions of the Warrant Certificate)
and on and subject to the other terms and conditions specified in the Warrant Certificate and hereunder and encloses herewith
a certified cheque, bank draft or money order in lawful money of the United States of America payable to the Corporation or has
transmitted same day funds in lawful money of the United States of America by wire to such account as the Corporation directed
the undersigned in payment of the subscription price.

 

By executing this subscription form, the undersigned hereby
acknowledges, represents and warrants:

 

		(1)	That the following legends will
                                         be placed on the certificates representing the Common Shares being acquired if the Warrants
                                         are exercised prior to four months plus one day from the Issuance Date:

 

"UNLESS PERMITTED UNDER SECURITIES
LEGISLATION, THE HOLDER OF THE SECURITIES REPRESENTED BY THIS CERTIFICATE SHALL NOT TRADE THE SECURITIES BEFORE THE DATE THAT
IS 4 MONTHS AND A DAY AFTER ●, 2020.

 

WITHOUT PRIOR WRITTEN APPROVAL
OF THE TSX VENTURE EXCHANGE AND COMPLIANCE WITH ALL APPLICABLE SECURITIES LEGISLATION, THE SECURITIES REPRESENTED BY THIS CERTIFICATE
MAY NOT BE SOLD, TRANSFERRED, HYPOTHECATED OR OTHERWISE TRADED ON OR THROUGH THE FACILITIES OF THE TSX VENTURE EXCHANGE OR OTHERWISE
IN CANADA OR TO OR FOR THE BENEFIT OF A CANADIAN RESIDENT UNTIL ●."

 

and, in addition to the foregoing
legends, the following legends will be placed on the certificates representing the Common Shares irrespective of the date of exercise:

 

“THE SECURITIES REPRESENTED
BY THIS CERTIFICATE HAVE NOT BEEN REGISTERED UNDER THE U.S. SECURITIES ACT OF 1933, AS AMENDED (THE "SECURITIES ACT"),
OR UNDER ANY STATE SECURITIES LAWS. NEITHER THIS SECURITY NOR ANY INTEREST OR PARTICIPATION HEREIN MAY BE OFFERED, SOLD, ASSIGNED,
PLEDGED, ENCUMBERED OR OTHERWISE TRANSFERRED WITHIN THE UNITED STATES OR TO, OR FOR THE ACCOUNT OR BENEFIT OF, U.S. PERSONS IN
THE ABSENCE OF SUCH REGISTRATION UNLESS SUCH TRANSACTION IS EXEMPT FROM, OR NOT SUBJECT TO, REGISTRATION UNDER THE SECURITIES
ACT, AND EXCEPT AS SET FORTH BELOW.

 

     

    I 18

    

 

BY ITS ACQUISITION HEREOF, THE
HOLDER AGREES THAT IT WILL NOT OFFER, RESELL OR OTHERWISE TRANSFER THIS SECURITY, EXCEPT (A) PURSUANT TO AN EFFECTIVE REGISTRATION
STATEMENT UNDER THE SECURITIES ACT, (B) TO ASSURE HOLDINGS CORP., (C) IN COMPLIANCE WITH (i) RULE 144A UNDER THE U.S. SECURITIES
ACT TO A PERSON THE SELLER REASONABLY BELIEVES TO BE A QUALIFIED INSTITUTIONAL BUYER (AS DEFINED IN RULE 144A); OR (ii) RULE 144
UNDER THE U.S. SECURITIES ACT (“RULE 144”), IF AVAILABLE (D) OUTSIDE THE UNITED STATES IN AN OFFSHORE TRANSACTION
IN COMPLIANCE WITH REGULATION S UNDER THE SECURITIES ACT, OR (E) PURSUANT TO AN EXEMPTION FROM REGISTRATION UNDER THE SECURITIES
ACT AND IN COMPLIANCE WITH ANY APPLICABLE STATE SECURITIES LAWS.

 

FOR ANY TRANSFER PURSUANT TO REGULATION
S UNDER THE SECURITIES ACT OF THE SECURITY EVIDENCED HEREBY PRIOR TO THE RESTRICTION TERMINATION DATE, THE TRANSFEREE AGREES THAT
IT WILL DELIVER TO EACH PERSON TO WHOM THIS SECURITY IS TRANSFERRED A NOTICE SUBSTANTIALLY TO THE EFFECT OF THIS LEGEND.

 

FOR ANY TRANSFER PURSUANT TO REGULATION
S UNDER THE SECURITIES ACT OF THE SECURITY EVIDENCED HEREBY PRIOR TO THE RESTRICTION TERMINATION DATE, THE TRANSFEREE MUST MAKE
CERTAIN CERTIFICATIONS TO THE COMPANY OR TRANSFER AGENT TO CONFIRM THAT SUCH TRANSFEREE IS NOT A U.S. PERSON UNDER REGULATION
S UNDER THE SECURITIES ACT AND PROVIDE CERTAIN OTHER CERTIFICATIONS AND AGREEMENTS THAT SUCH TRANSFERS ARE BEING MADE PURSUANT
TO AN EXEMPTION FROM, OR IN A TRANSACTION NOT SUBJECT TO, THE REGISTRATION REQUIREMENTS OF THE SECURITIES ACT.

 

ADDITIONALLY, FOR ANY TRANSFER
REFERRED TO IN CLAUSE (C)(ii) or (E), OR IF REQUESTED BY ASSURE HOLDINGS CORP. OR THE TRANSFER AGENT FOR THE SECURITIES, (D),
THE HOLDER MUST, PRIOR TO SUCH TRANSFER, FURNISH TO THE COMPANY OR TRANSFER AGENT SUCH CERTIFICATIONS, LEGAL OPINIONS OR OTHER
INFORMATION AS THE COMPANY OR THE TRANSFER AGENT MAY REASONABLY REQUIRE TO CONFIRM THAT SUCH TRANSFER IS BEING MADE PURSUANT TO
AN EXEMPTION FROM OR IN A TRANSACTION NOT SUBJECT TO THE REGISTRATION REQUIREMENT OF THE SECURITIES ACT.

 

THE HOLDER HEREOF AGREES THAT
IT WILL NOT, DIRECTLY OR INDIRECTLY, ENGAGE IN ANY HEDGING TRANSACTION WITH REGARD TO THE SECURITIES EXCEPT AS PERMITTED BY THE
SECURITIES ACT.

 

 

     

    I 19

    

 

“RESTRICTION TERMINATION
DATE” AS USED HEREIN SHALL MEAN ONE YEAR AFTER THE LATER TO OCCUR OF THE ACQUISITION OF THE SECURITY EVIDENCED HEREBY FROM
(X) ASSURE HOLDINGS CORP. OR (Y) ANY AFFILIATE OF ASSURE HOLDINGS CORP.”

 

(2)        
That the undersigned is not a U.S. Person, or a Person in the United States, and is not acquiring any of the Common Shares
issuable upon the exercise of the Warrants for the account or benefit of, a U.S. Person or Person in the United States and none
of the persons listed above is a U.S. Person or a Person in the United States. For purposes hereof, (a) "United States"
means the United States of America, its territories or possessions, any state thereof or the District of Columbia and (b) a "U.S.
Person" means any natural person resident in the United States, any partnership or corporation organized or incorporated
under the laws of the United States, any estate of which any executor or administrator is a U.S. Person, any trust of which any
trustee is a U.S. Person, any agency or branch of a foreign entity located in the United States, any non-discretionary account
or similar account (other than an estate or trust) held by a dealer or other fiduciary for the benefit or account of a U.S. Person,
any discretionary account or similar account (other than an estate or trust) held by a dealer or other fiduciary organized or
incorporated, or, if an individual, resident, in the United States or any partnership or corporation organized or incorporated
under the laws of a country other than the United States if formed by a U.S. Person principally for the purpose of investing in
securities not registered under the United States Securities Act of 1933, as amended.

 

<<The remainder
of this page is intentionally left blank>>

 

     

    I 20

    

 

The undersigned hereby directs that the Common Shares subscribed
for pursuant to the exercise of the Warrant be registered in the name of and delivered as follows:

 

	Name
    in Full	Address	Number
    of Warrants Hereby
	 	 	Exercised
	 	 	 

 

DATED this ___ day of _____________, 20____.

 

	 	 	 
	 	 	(Print Name)
	 	 	 
	 	By:	 
	 	 	(Signature)

 

     

    I 21

    

 

SCHEDULE B

 

FORM OF TRANSFER

 

FOR VALUE RECEIVED, the undersigned hereby
sells, assigns and transfers unto _________________________________________________________________________________________________________________________
(include name and address of the transferee) Warrants exercisable for common shares of Assure Holdings Corp. (the "Corporation")
registered in the name of the undersigned on the register of the Corporation maintained therefore, and hereby irrevocably appoints
the attorney of the undersigned to transfer the said securities on the books maintained by the Corporation with full power of
substitution.

 

DATED this _________ day of ___________________, 20____.

 

	Signature of Transferor guaranteed
    by:	 	 
	 	 	 
	 	 	 
	Name of Bank or Trust Company:	 	Signature of Transferor
	 	 	 
	 	 	 
	 	 	 
	 	 	 
	 	 	 
	 	 	 
	 	 	Address of Transferor

 

Notes:

 

		1.	The signature to this transfer must
                                         correspond with the name written upon the face of this Warrant Certificate in every particular
                                         without any changes whatsoever.

 

		2.	If the Transfer Form
                                         indicates that Common Shares are to be issued to a person or persons other than the registered
                                         holder of the Warrant Certificate, the signature on this Transfer Form must be guaranteed
                                         by a Schedule I chartered bank or licensed trust company, or a member of an acceptable
                                         medallion guarantee program. The guarantor must affix a stamp bearing the actual words
                                         "Signature Guaranteed". Signature guarantees are not accepted from Treasury
                                         Branches or credit unions unless they are members of the Stamp Medallion Program.Exhibit 10.1

 

Execution Copy

 

 

SHARE EXCHANGE AGREEMENT

 

AMONG:

 

MONTREUX CAPITAL CORP.

 

-and -

 

The Persons Listed on

 

SCHEDULE A

 

-and -

 

ASSURE HOLDINGS INC.

 

May 16, 2017

 

    

    - i -

    

 

	 	TABLE OF CONTENTS	
	ARTICLE 1 DEFINITIONS 	2
	1.1	Definitions 	2
	1.2	Hereof, Herein, etc.	6
	1.3	Computation of Time Periods	6
	1.4	Knowledge	7
	1.5	Schedules	7
	ARTICLE 2 AGREEMENT TO EXCHANGE	8
	2.1	Share Exchange	8
	2.2	Maximum Number of Montreux Shares	8
	2.3	Closing and Delivery of Certificates	8
	2.4	Tax Election	9
	2.5	Escrow	9
	2.6	Effective Date	9
	2.7	Share Capital	9
	ARTICLE 3 REPRESENTATIONS AND
WARRANTIES OF ASSURE	9
	3.1	Organization and Existence	9
	3.2	Subsidiaries	10
	3.3	Authorization	10
	3.4	Authorized Capital	10
	3.5	Information	10
	3.6	Assure Financial Statements	11
	3.7	No Other Agreement to Purchase	11
	3.8	Absence of Certain Changes	11
	3.9	Indebtedness to Directors, Officers and Others	12
	3.10	Rights of Directors, Officers and Others	12
	3.11	Taxes	12
	3.12	Property Rights	13
	3.13	Joint Ventures	13
	3.14	Restrictive Covenants 	13
	3.15	Material Contracts	13
	3.16	Necessary Licenses and Permits 	13
	3.17	Compliance with Law	14
	3.18	Employees 	14
	3.19	Employee Benefit Plans	14
	3.20	Litigation 	14
	3.21	No Material Adverse Change	14
	3.22	Insurance	14
	3.23	Corporate Documents, Books and Records	14
	3.24	No Limitations	15
	3.25	Reporting Issuer Status	15
	3.26	Regulatory Compliance	15
	3.27	Environmental Compliance	15
	3.28	Non-Arm’s Length Transactions	15
	3.29	Enforceability	15
	3.30	Technical Report	15

 

    

    - ii - 

    

 

	3.31 	Information Supplied 	15
	ARTICLE 4 REPRESENTATIONS AND WARRANTIES OF ASSURE SHAREHOLDERS 	15
	4.1 	Capacity	15
	4.2 	Execution and Delivery	16
	4.3 	No Violation.	16
	4.4 	Ownership	16
	ARTICLE 5 REPRESENTATIONS AND WARRANTIES OF MONTREUX	16
	5.1 	Organization and Existence	16
	5.2 	Authorization	17
	5.3 	Consents	17
	5.4 	Authorized Capital	17
	5.5 	No Material Adverse Change	17
	5.6 	Reporting Issuer Status	18
	5.7 	TSXV Listing	18
	5.8 	Reports and Montreux Financial Statements	18
	5.9 	Absence of Certain Changes	18
	5.10 	Corporate Documents, Books and Records	19
	5.11 	Information	19
	5.12 	No Other Agreement to Purchase 	20
	5.13 	Shareholder Loans	20
	5.14 	Indebtedness and Liens	20
	5.15	Indebtedness to Officers, Directors and Others	20
	5.16 	Taxes	20
	5.17 	Title to Assets	20
	5.18 	Material Contracts	20
	5.19 	Title to Property	21
	5.20 	Necessary Licenses and Permits	21
	5.21 	Compliance with Law	21
	5.22 	Employees	21
	5.23 	Litigation	21
	5.24 	Employee Benefit Plans	22
	5.25 	Inventory	22
	5.26	Insurance	22
	5.27 	No Limitations	22
	5.28	Regulatory Compliance	22
	5.29 	Non-Arm’s Length Transactions	22
	5.30 	Enforceability	22
	5.31 	Information Supplied	23
	ARTICLE 6 COVENANTS	23
	6.1 	Filings	23
	6.2 	Additional Agreements	23
	6.3 	Access to Information	24
	6.4 	Conduct of Business of Assure.	24
	6.5 	Conduct of Business of Montreux	25

 

    

    - iii -

    

 

	ARTICLE
    7 CONDITIONS TO OBLIGATION TO CLOSE	26
	7.1
    	Montreux’s
    Closing Conditions	28
	7.2
    	Assure’s Closing
    Conditions	30
	ARTICLE
    8 TERMINATION	30
	8.1
    	Termination	31
	8.2
    	Effect of Termination	31
	8.3
    	Waivers and Extensions	31
	ARTICLE
    9 TRANSACTION COSTS	31
	9.1
    	Transaction Costs	31
	ARTICLE
    10 NOTICES	31
	10.1	Notices	31
	ARTICLE
    11 INDEMNIFICATION	33
	11.1
    	Survival of Covenants,
    Agreements, Etc.	33
	11.2
    	Indemnification by Assure
    	33
	11.3
    	Indemnification by Montreux
    	34
	11.4	Notice of Claim 	34
	11.5
    	Direct Claims  	34
	11.6
    	Third Party Claims 	35
	11.7	Settlement of Third
    Party Claims	35
	11.8
    	Co-operation	35
	11.9	Exclusivity	35
	ARTICLE
    12 MISCELLANEOUS	35
	12.1
    	Amendments and Waivers
    	35
	12.2
    	Consent to Jurisdiction
    	36
	12.3	Governing Law 	36
	12.4
    	Further Assurances 	36
	12.5
    	Time	36
	12.6
    	Assignment	36
	12.7
    	Public Announcement;
    Disclosure 	36
	12.8	Entire Agreement, Counterparts,Section
    Headings 	37
	12.9	Regulatory Approval
    	37

 

	SCHEDULES:
	 
	 	Schedule
    A	-
    	Assure
    Shareholders
	 	Schedule
    B	-
    	Assure
    Convertible Security Holders
	 	Schedule
    3.14	-
    	Assure
    Material Contracts
	 	Schedule
    5.18	-
    	Montreux
    Material Contracts

 

    

    1

    

  

SHARES EXCHANGE AGREEMENT

 

THIS AGREEMENT made
as of the 16th day of May, 2017,

 

AMONG:

 

ASSURE HOLDINGS, INC.,

a corporation incorporated under the laws of the State
of Colorado

 

(“Assure”)

 

AND

 

 

The Persons Listed on SCHEDULE A,

 

(Each, an “Assure Shareholder”
and collectively, the “Assure Shareholders”)

 

AND

 

MONTREUX CAPITAL CORP.,

a corporation incorporated under the laws of the Province
of British Columbia

 

(“Montreux”)

 

WHEREAS
the Assure Shareholders are the registered and beneficial owners of all of the issued and outstanding common shares
in the capital of Assure (each, an “Assure Share” and collectively, the “Assure Shares”);

 

AND
WHEREAS Montreux is a reporting issuer in the provinces of British Columbia and Alberta whose common shares are listed
on the TSX Venture Exchange (the “TSXV”);

 

AND
WHEREAS Montreux and Assure and the Assure Shareholders wish to exchange securities on the terms and conditions herein
contained;

 

AND WHEREAS
immediately following such transactions, Montreux and Assure will effect a share transfer such that Montreux will directly
own all of the Assure Shares, and the Assure Shareholders will in the aggregate own approximately 69.5% of the aggregate number
of common shares of Montreux (the “Montreux Shares”);

 

AND WHEREAS on
March 2, 2017, Assure issued 6,392,060 subscription receipts (each a

 

“Subscription Receipt”
and together, the “Subscription Receipts”) at a price of $0.50 per Subscription Receipt for gross proceeds of
$3,196,030 (the “Financing”);

 

AND
WHEREAS the Acquisition (as defined below) is intended to serve as Montreux’s “Qualifying Transaction”
pursuant to TSXV Policy 2.4 – Capital Pool Companies;

 

NOW
THEREFORE, in consideration of the premises and the mutual covenants contained herein and other good and valuable consideration,
the receipt and sufficiency of which is hereby acknowledged, the parties hereto hereby covenant and agree as follows:

 

    

    2

    

 

ARTICLE 1

DEFINITIONS

 

1.1       Definitions

 

For all purposes of this Agreement
the following capitalized terms shall have the meanings set forth in this Article 1:

 

“Acquisition”
means the acquisition by Montreux of all of the issued and outstanding Assure Shares in exchange for the issuance of Montreux Shares
to the Assure Shareholders for the purposes of effecting a “Qualifying Transaction” within the meaning of the CPC Policy.

 

“Affiliate”
of an entity means any Person directly or indirectly controlling, controlled by or under direct or indirect common control with
such entity.

 

“Agent” means Leede Jones Gable Inc.

 

“Articles” means
the certificate and articles of incorporation (as amended), certificate and articles of organization (as amended), constitution,
by-laws, operating agreement, joint venture or partnership agreement or articles or other constituting document of any Person other
than an individual, each as from time to time amended or modified.

 

“Assure Assets” means all assets
owned by Assure, including the shares of Assure Neuromonitoring and Assure Networks.

 

“Assure Convertible
Securities” means collectively the 3,200,000 Assure Options, the 459,600 Assure Broker Warrants and the 6,000,000
Assure Performance Shares.

 

“Assure Financial Statements” has the meaning
set forth in Section 3.6.

 

“Assure Networks” means Assure Networks,
LLC, a limited liability company formed under the laws of the State of Colorado on November 2, 2016; being a wholly owned subsidiary
of Assure.

 

“Assure
Neuromonitoring” means Assure Neuromonitoring, LLC, a limited liability company formed under the laws of the State
of Colorado on August 25, 2015, being a wholly owned subsidiary of Assure.

 

“Assure Broker Warrants”
means the Broker Warrants of Assure to purchase 459,600 Assure Shares, the whole as set forth in Schedule “B”, at a
price of C$0.50 per Assure Share until March 2, 2019, to be exchanged for 459,600 Montreux Broker Warrants on the same terms and
conditions as the Assure Broker Warrants.

 

“Assure Options” means the 3,200,000 options
to purchase Assure Shares, the whole as set forth in

 

Schedule “B”, to be
exchanged for 3,200,000 options to purchase Montreux Shares, on the same terms and conditions as the Assure Options.

 

“Assure Performance Shares”
means the 6,000,000 performance shares, as set forth in Schedule “B”, to be exchanged for 6,000,000 Montreux Performance
Shares.

 

“Assure Shareholders”
means, collectively, the Persons identified in Schedule A to this Agreement as the registered and beneficial holders of all the
Assure Shares.

 

    

    3

    

 

“Assure Shares” means, collectively,
all of the common shares of Assure as issued and outstanding from time to time.

 

“Business Day”
means a day, excluding Saturday and Sunday, on which banking institutions are open for business in Toronto, Ontario and Vancouver,
British Columbia.

 

“Change of Control”
means the acquisition, directly or indirectly, of beneficial ownership of voting securities that results in a holding of more than
20% of the issued and outstanding voting securities of Assure by a third party, other than in connection with this Agreement or
an internal corporate reorganization.

 

“Claim” has the meaning set forth
in Section 11.4.

 

“Closing” means the closing of the
Acquisition pursuant to the terms of this Agreement.

 

“Closing Date”
means such date as Assure and Montreux shall determine for Closing but in any event no later than May 31, 2017.

 

“Closing Time” means 8:00 a.m. (Vancouver
time) on the Closing Date.

 

“Control”
in respect of a Person (including the terms “controlled by” and “under common control with”)
means the possession, directly or indirectly, of the power to direct or cause the direction of the management and policies of a
Person, whether through ownership of voting securities, by contract or by other arrangement.

 

“CPC Policy” means policy 2.4 Capital
Pool Companies of the TSXV.

 

“Direct Claim” has the meaning set
forth in Section 11.4.

 

“Distribution”
means: (a) the declaration or payment of any dividend in cash, securities or property on or in respect of any class of securities
of the Person or its Subsidiaries; (b) the purchase, redemption or other retirement of any securities of the Person or its Subsidiaries,
directly or indirectly; or (c) any other distribution on or in respect of any class of securities of the Person or its Subsidiaries.

 

“Dollars” and “$”
means Canadian dollars, unless otherwise specified.

 

“Escrowed Proceeds”
means the cash amount of $3,196,030, being the gross proceeds of the Financing, delivered to the Subscription Receipt Agent and
held in escrow on the terms and subject to the conditions of the Subscription Receipt Agreement entered into among Assure, the
Subscription Receipt Agent and the Agent, dated March 2, 2017, as confirmed in writing by Assure.

 

“Financing” has the meaning given
to it in the recitals of this Agreement.

 

“IFRS” means
International Financial Reporting Standards as issued by the International Accounting Standards Board.

 

“Income Tax Act” means the Income
Tax Act (Canada), as amended from time to time.

 

    

    4

    

 

“Indebtedness”
means all obligations, contingent (to the extent required to be reflected in financial statements prepared in accordance with
IFRS) and otherwise, which in accordance with IFRS should be classified on the obligor’s balance sheet as liabilities,
including without limitation, in any event and whether or not so classified: (a) all debt and similar monetary obligations,
whether direct or indirect; (b) all liabilities secured by any mortgage, pledge, security interest, lien, charge or other
encumbrance existing on property owned or acquired subject thereto, whether or not the liability secured thereby shall have
been assumed; (c) all agreements of guarantee, support, indemnification, assumption or endorsement and other contingent
obligations whether direct or indirect in respect of Indebtedness or performance of others, including any obligation to
supply funds to or in any manner to invest in, directly or indirectly, the debtor, to purchase Indebtedness, or to assure the
owner of Indebtedness against loss, through an agreement to purchase goods, supplies or services for the purpose of enabling
the debtor to make payment of the Indebtedness held by such owner or otherwise; (d) obligations to reimburse issuers of any
letters of credit; and (e) capital leases.

 

“Indemnified Party” has the meaning set forth
in Section 11.4.

 

“Insider” has the meaning given to such term
in Policy 1.1 of the TSXV Corporate Finance Manual.

 

“Laws” mean all federal,
provincial, state, municipal or local laws, rules, regulations, statutes, by-laws, ordinances, policies or orders of any federal,
provincial, state, regional or local government or any subdivision thereof or any arbitrator, court, administrative or regulatory
agency, commission, department, board or bureau or body or other government or authority or instrumentality or any entity or Person
exercising executive, legislative, judicial, regulatory or administrative functions of or pertaining to government.

 

“Lien” means: (a) any
encumbrance, mortgage, pledge, hypothec, prior claim, lien, charge or other security interest of any kind upon any property or
assets of any character, or upon the income or profits therefrom; (b) any acquisition of or agreement to have an option to acquire
any property or assets upon conditional sale or other title retention agreement, device or arrangement (including a capitalized
lease); or (c) any sale, assignment, pledge or other transfer for security of any accounts, general intangibles or chattel paper,
with or without recourse.

 

“Losses”, in respect
of any matter, means all claims, demands, proceedings, losses, damages, liabilities, deficiencies, costs and expenses (including,
without limitation, all legal and other professional fees and disbursements, interest, penalties and amounts paid in settlement)
arising directly or indirectly as a consequence of such matter.

 

“Material Adverse Effect”
in respect of a Person means any change, effect, event, occurrence, condition or development that has or could reasonably be expected
to have, individually or in the aggregate, a material and adverse impact on the business, operations, results of operations, assets,
capitalization or financial condition of such Person, other than any change, effect, event, occurrence or state of facts relating
to the global economy or securities markets in general.

 

“Montreux Assets” means all assets owned
by Montreux, including but not limited to cash.

 

“Montreux Filing Statement”
means the filing statement to be prepared by Montreux in accordance with Form 3B2 in respect of a qualifying transaction.

 

“Montreux Financial Statements” has the meaning
set forth in Section 5.8(a).

 

“Montreux Options” means options to
acquire Montreux Shares to be issued to the holders of Assure Options in replacement of the Assure Options, as set forth in
Schedule “B” hereto.

 

“Montreux Plan” means the stock option plan
of Montreux.

 

    

    5

    

 

“Montreux
Performance Shares” means the performance shares of Montreux to be issued to certain Assure Shareholders in
replacement of the Assure Performance Shares, as set forth in Schedule “B” hereto.

 

“Montreux Shareholders” means, collectively,
the registered and beneficial holders of all the Montreux Shares.

 

“Montreux Shares” means the common
shares in the capital of Montreux, on a pre-Share Consolidation or post-Share Consolidation basis, as applicable in the context.

 

“Montreux Warrants” mean the warrants
outstanding in the capital of Montreux, each such warrant entitling the holder thereof to acquire one Montreux Share at $0.05 until
September 29, 2018.

 

“Permitted Liens” means:

 

		(a)	undetermined or inchoate Liens and charges incidental to construction, maintenance
or operations or otherwise relating to the ordinary course of business which have not at the time been filed pursuant to law;

 

		(b)	Liens for taxes and assessments for the then current year, Liens for taxes
and assessments not at the time overdue, Liens securing worker’s compensation assessments and Liens for specified taxes and
assessments which are overdue (and which have been disclosed to the other parties to this Agreement) but the validity of which
is being contested at the time in good faith, if the Person shall have made on its books provision reasonably deemed by it to be
adequate therefor;

 

		(c)	cash or governmental obligations deposited in the ordinary course of business
in connection with contracts, bids, tenders or to secure worker’s compensation, unemployment insurance, surety or appeal
bonds, costs of litigation, when required by law, public and statutory obligations, Liens or claims incidental to current construction,
and mechanics’, warehousemen’s, carriers’ and other similar Liens;

 

		(d)	all rights reserved to or vested in any governmental body by the terms of any
lease, licence, franchise, grant or permit held by it or by any statutory provision to terminate any such lease, licence, franchise,
grant or permit or to require annual or periodic payments as a condition of the continuance thereof or to distrain against or to
obtain a Lien on any of its property or assets in the event of failure to make such annual or other periodic payments; and

 

		(e)	Purchase Money Obligations.

 

“Person” means
an individual, partnership, corporation, association, trust, joint venture, unincorporated organization and any government, governmental
department or agency or political subdivision thereof.

 

“Purchase Money Obligations”
means Indebtedness of a debtor, reflected in the debtor’s financial statements, and incurred or assumed to finance the purchase
or acquisition, in whole or in part, of any tangible real or personal property or incurred to finance the cost, in whole or in
part, of the construction or installation of any tangible personal property, provided, however, that such Indebtedness is incurred
or assumed at the time of or within 30 days after the purchase of such property or the completion of such construction or installation,
as the case may be, and include any extension, renewal or refinancing of any such Indebtedness so long as the principal amount
thereof outstanding at the date of such extension, renewal or refinancing is not increased.

 

    

    6

    

 

“Release Condition” means collectively, the
following conditions:

 

		(a)	other than the release of the Escrowed Proceeds plus all interest and income, if any, earned thereon,
all of the conditions to the completion of this Agreement having been satisfied or waived in a manner satisfactory to the Corporation
and the Agent and as further set forth in the Agency Agreement; and

 

		(b)	the Corporation and the Agent having delivered the release notice to the Subscription Receipt Agent
pursuant to the Subscription Release Agreement;

 

“Share Consolidation” has the meaning
set forth in Section 2.1(b).

 

“Share Exchange”
means the exchange of Assure Shares for Montreux Shares, all as provided for herein, pursuant to which Montreux will directly and
indirectly own all of the Assure Shares and the Assure Shareholders will in the aggregate own approximately 69.5% of the aggregate
number of Montreux Shares, prior to giving effect to the Financing.

 

“Subscription Receipt Agent” means
Computershare Trust Company of Canada.

 

“Subsidiary” shall have the same
meaning as the term “subsidiary” in the Securities Act (British Columbia).

 

“Tax” or “Taxes”
means all taxes, charges, fees, levies, imposts and other assessments, including all income, sales, use, goods and services, value
added, capital, capital gains, alternative net worth, transfer, profits, withholding, payroll, employer health, employer safety,
workers compensation, excise, immovable property and moveable property taxes, and any other taxes, customs duties, fees, assessments
or similar charges in the nature of a tax including Canada Pension Plan, Social Security and provincial plan contributions and
workers compensation premiums, together with any interest, fines and penalties imposed by any governmental authority (including
federal, provincial, municipal and oreign governmental authorities), and whether disputed or not.

 

“Tax Returns” has the meaning set
forth in Section 3.11.

 

“Third Party Claim” has the meaning
set forth in Section 11.4.

 

1.2       Hereof,
Herein, etc.

 

The words “hereof”,
 “herein” and “hereunder” and words of similar import when used in this Agreement shall refer to this Agreement
as a whole and not to any particular provision of this Agreement. Unless otherwise specified herein, the term “or”
has the inclusive meaning represented by the term “and/or” and the term “including” is not limiting. All
references as to “Sections”, “Subsections”, “Articles”, “Schedules” and “Exhibits”
shall be to Sections, Subsections, Articles, Schedules and Exhibits, respectively, of this Agreement unless otherwise specifically
provided.

 

1.3       Computation
of Time Periods

 

In the computation of periods
of time from a specified date to a later specified date, unless otherwise specified herein, the words “commencing on”
mean “commencing on and including”, the word “from” means “from and including” and the words
 “to” and “until” each means “to and including”.

 

    

    7

    

 

1.4       Knowledge

 

Whenever used in this Agreement, a statement
qualified by the phrase “to the knowledge of” or similar statement is intended to be a statement of the knowledge of
the Person or senior officers of the Person regarding the facts or circumstances to which the phrase relates, after having made
due inquiries and investigations with respect to such facts or circumstances.

 

1.5       Schedules

 

The following Schedules are attached hereto and form part of
this Agreement:

 

	Schedule A	-	Assure Shareholders
	Schedule B	-	Assure Convertible Security Holders
	Schedule 3.14	-	Assure Material Contracts
	Schedule 5.18	-	Montreux Material Contracts

 

    

    8

    

 

ARTICLE 2

AGREEMENT TO EXCHANGE

 

2.1          Share
Exchange

 

		(a)	Subject to all of the terms and conditions hereof and in reliance on the representations
and warranties set forth or referred to herein, at the Closing Time each of the Assure Shareholders separately agrees to exchange,
transfer and assign all of the Assure Shares he or it owns or will own at the Closing Time (being the number set out opposite his
or its name in the attached Schedule A) to Montreux in consideration of Montreux’s issuance to such Assure Shareholder of
that number of Montreux Shares set out opposite his or its name in the said Schedule A.

 

		(b)	Immediately prior to Closing, Montreux shall effect a share consolidation of
the Montreux Shares on the basis of one (1) “new” Montreux Share for every three (3) “old” Montreux Shares
(the

 

“Share Consolidation”).

 

		(c)	The exchange, transfer and assignment of Assure Shares for Montreux Shares
shall proceed on the basis of one (1) Montreux Share (post-Share Consolidation) for each one (1) Assure Share.

 

		(d)	Fractional Montreux Shares shall not be issued or otherwise provided for.

 

2.2          Deemed
Value of Montreux Shares

 

The parties acknowledge and agree that the Montreux
Shares will be issued at a deemed value of $0.50 per Montreux Share.

 

2.3          Closing
and Delivery of Certificates

 

		(a)	The Closing shall take place at the Toronto office of Minden Gross LLP, at
the Closing Time on the Closing Date, or as Assure and Montreux may otherwise agree in writing.

 

		(b)	Subject to the satisfaction of the conditions to the obligation to close the
transactions contemplated herein set forth in Article 7 each Assure Shareholder shall transfer and deliver to Montreux at the Closing
Time certificates representing the Assure Shares set out opposite their name in the attached Schedule A duly endorsed in blank
for transfer or accompanied by a duly executed power of attorney for transfer in blank.

 

		(c)	Subject to compliance with Section 2.3(b), Montreux shall deliver to the Assure
Shareholders at the Closing Time certificates representing the number of Montreux Shares set out opposite their respective names
in the attached Schedule A, and shall enter the Assure Shareholders on the books of Montreux as the holders of such Montreux Shares.

 

		(d)	Each Assure Shareholder hereby agrees that Assure shall have the authority
to act on their behalf at Closing and to deliver, on behalf of the Assure Shareholders, all documents contemplated in section 2.3(b),
any notice, direction, consent, waiver, extension or other communication and Montreux shall be entitled to and shall act on any
such notice, direction, consent, waiver, extension or other communication.

 

		(e)	Subject to compliance with Section 2.3 (b), Montreux shall deliver to the holders of Assure Options, Assure Performance
Shares and Assure Broker Warrants at the Closing Time certificates representing that number of Assure Options, Assure Performance
Shares and Assure Broker Warrants set out opposite their respective names in the attached Schedule B, and shall enter each of the
holders of Assure Options, Assure Performance Shares and Assure Broker Warrants on the books of Montreux as the holders of such
securities.

 

    

    9

    

 

		2.4	Intentionally deleted 

 

		2.5	Escrow 

 

The Assure Shareholders acknowledge
that Montreux Shares acquired by them pursuant to this Agreement may be escrowed pursuant to the policies of the TSXV. In circumstances
where Persons other than Insiders of Montreux after the Closing Date are to have Montreux Shares escrowed, Montreux and Assure
will use reasonable commercial efforts to inform such affected Persons in advance of the Closing Date.

 

2.6          Effective
Date

 

The exchange of Assure Shares for Montreux Shares
shall take effect at and from the Closing Time.

 

2.7          Share
Capital

 

For greater certainty, the parties
acknowledge that 34,528,393 Montreux Shares will be issued and outstanding after the Closing of which (i) an aggregate of approximately
24,000,000 Montreux Shares shall be held by Assure Shareholders, (ii) an aggregate of 6,392,060 Montreux Shares shall be held by
holders of the Subscription Receipts; and (iii) an aggregate of 4,136,333 Montreux Shares shall be held by the current shareholders
of Montreux.

 

ARTICLE 3

REPRESENTATIONS AND WARRANTIES OF ASSURE

 

In order to induce Montreux to
enter into this Agreement and to consummate the transactions contemplated by this Agreement, Assure hereby represents and warrants
as follows to and in favour of Montreux and acknowledge that Montreux is relying upon such representations and warranties in connection
with the Share Exchange. All references to “Assure” in this Article 3 includes the Subsidiaries of Assure unless the
context otherwise requires:

 

3.1          Organization
and Existence

 

Assure is a corporation duly
incorporated and each of Assure Neuromonitoring and Assure Networks is a limited liability company duly organized and validly existing
under the laws of its jurisdiction of organization and has the corporate power to own its properties and to carry on its business
as now conducted and has made all necessary filings under all applicable corporate, securities and taxation laws or any other laws
to which it is subject, except where the failure to make such filing would not have a Material Adverse Effect on Assure. Assure
does not have any Subsidiaries other than Assure Neuromonitoring and Assure Networks. No proceedings have been instituted or are
pending for the dissolution or liquidation of Assure, Assure Neuromonitoring or Assure Networks.

 

    

    10

    

 

3.2          Subsidiaries

 

Assure does not beneficially own, or exercise
control or direction over, 10% or more of the outstanding voting shares of any company other than Assure Neuromonitoring and Assure
Networks and Assure beneficially owns, directly or indirectly, all of the issued and outstanding shares in the capital of each
of Assure Neuromonitoring and Assure Networks free and clear of all mortgages, liens, charges, pledges, security interests, encumbrances,
claims or demands of any kind whatsoever, all of such shares have been duly authorized and validly issued and are outstanding as
fully paid and non-assessable shares and no person has any right, agreement or option, present or future, contingent or absolute,
or any right capable of becoming a right, agreement or option, for the purchase from Assure of any interest in any of such shares
or for the issue or allotment of any unissued shares in the capital of either Assure Neuromonitoring or Assure Networks or any
other security convertible into or exchangeable for any such shares.

 

3.3          Authorization

 

The execution, delivery and performance
by Assure of this Agreement and the Share Exchange: (i) are within its corporate power and authority; (ii) have been, or will be
duly authorized by all necessary corporate proceedings; and (iii) do not and will not conflict with or result in any breach of
any provision of, or the creation of any Lien upon any of the property of Assure or result in any Material Adverse Effect on Assure
or any of its property pursuant to the Articles of Assure, any Laws, order, judgment, injunction, license or permit applicable
to Assure or any indenture, lease, agreement, contract, instrument or Lien, to which Assure is a party or by which the property
of Assure may be bound or affected.

 

3.4          Authorized
Capital

 

		(a)	The authorized capital of Assure consists of 100,000,000 Assure Shares of which 24,000,000 Assure
Shares are issued and outstanding as at the date hereof. Assure may issue up to an additional 3,200,000 Assure Shares upon exercise
of the Assure Options, 6,000,000 Assure Shares pursuant to the terms of the Assure Performance Shares and 459,600 Assure Shares
upon exercise of the Assure Broker Warrants.

 

		(b)	The Assure Shares issued and outstanding as at the Closing Time have been, or will at the Closing
Time be, duly authorized and validly issued and outstanding as fully paid and non-assessable shares.

 

		(c)	The Subscription Receipts issued pursuant to the Financing have been, or will at the Closing Time,
upon receipt by the Subscription Receipt Agent of the release notice executed by Assure and the Agent confirming that the Release
Condition has been satisfied, be deemed automatically converted into the corresponding number of Assure Shares issuable upon the
conversion of such Subscription Receipts. For clarity, the holders of Subscription Receipts shall not be considered Assure Shareholders
for the purpose of this Agreement.

 

3.5          Information

 

All data and information provided by Assure
at the request of Montreux and its agents and representatives, to Montreux and its agents and representatives in connection with
the Share Exchange was and is complete and true and correct in all material respects as of the date thereof.

 

    

    11

    

 

3.6          Assure
Financial Statements

 

		(a)	Assure has delivered to Montreux true and complete copies of the audited consolidated financial
statements for the period ended December 31, 2016 (the “Assure Financial Statements”).

 

		(b)	The Assure Financial Statements were prepared in accordance with IFRS; the balance sheet included
in such Assure Financial Statements fairly presents the financial condition of Assure as at the close of business on the date thereof,
and the statement of operations and deficit included in the Assure Financial Statements fairly presents the results of operations
of Assure for the fiscal period then ended.

 

3.7          No
Other Agreement to Purchase

 

Other than as contemplated in Schedule
 “B”, there are no agreements, options, warrants, rights of conversion or other rights binding upon or which at any
time in the future may become binding upon Assure to issue any equity securities or any securities convertible or exchangeable,
directly or indirectly, into any equity securities of Assure. There are no shareholders’ agreements, pooling agreements,
voting trusts or other agreements or understandings with respect to the voting of the Assure Shares, or any of them.

 

3.8          Absence
of Certain Changes

 

Since December 31, 2016, Assure has not:

 

		(a)	except for in connection with the Financing, issued, sold, or agreed to issue, sell, pledge, hypothecate,
lease, dispose of or encumber any Assure Shares or other corporate securities or any right, option or warrant with respect thereto;

 

		(b)	amended or proposed to amend its Articles;

 

		(c)	split, combined or reclassified any of its securities or declared or made any Distribution;

 

		(d)	suffered any material loss relating to litigation or, to the knowledge of
Assure, been threatened with litigation;

 

		(e)	entered into or amended any employment contracts with any director, officer or senior management employee, created or amended
any employee benefit plan, made any increases in the base compensation, bonuses, paid vacation time allowed or fringe benefits
for its directors or officers;

 

		(f)	suffered damage, destruction or other casualty, loss, or forfeiture of, any property or assets,
whether or not covered by insurance;

 

		(g)	made any capital expenditures, additions or improvements or commitments for the same, except those
which do not exceed $20,000 per month;

 

		(h)	other than in the ordinary course of business: (i) entered into any contract, commitment or agreement
under which it has outstanding Indebtedness for borrowed money or for the deferred purchase price of property; or (ii) made any
loan or advance to any Person;

 

    

    12

    

 

		(i)	acquired or agreed to acquire (by tender offer, exchange offer, merger, amalgamation, acquisition
of shares or assets or otherwise) any Person, corporation, partnership, joint venture or other business organization or division
or acquired or agreed to acquire any material assets;

 

		(j)	except for in connection with the Financing, entered into any material contracts regarding its
business operations, including joint ventures, partnerships or other arrangements;

 

		(k)	created any stock option or bonus plan, paid any bonuses, deferred or otherwise, or deferred any
compensation to any of its directors or officers other than such payments made in the ordinary course of business;

 

		(l)	made any material change in accounting procedures or practices;

 

		(m)	mortgaged, hypothecated or pledged any of the Assure Assets, or subjected them to any Lien other
than a Permitted Lien;

 

		(n)	except for in connection with the Financing, entered into any other material transaction, or any
amendment of any contract, lease, agreement or license which is material to its business;

 

		(o)	sold, leased, subleased, assigned or transferred any of the Assure Assets;

 

		(p)	cancelled, waived or compromised any debts or claims, including accounts payable to and receivable
from its Affiliates;

 

		(q)	failed to pay or satisfy when due any liability of Assure where the failure to do so would have
a Material Adverse Effect on Assure; or

 

		(r)	entered into any agreement or understanding to do any of the foregoing.

 

3.9          Indebtedness
to Directors, Officers and Others

 

Assure is not indebted to any director, officer, employee
or consultant of Assure, except for amounts due as normal compensation or reimbursement of ordinary business expenses.

 

3.10        Rights
of Directors, Officers and Others

 

No director, officer, Insider
or other non-arm’s length party to Assure (or any Affiliate thereof) has any right, title or interest in (or the right to
acquire any right, title or interest in) any royalty interest, carried interest, participation interest or any other interest whatsoever
which are based on Assure’s business.

 

3.11        Taxes

 

All returns, declarations, reports,
estimates, statements, schedules or other information or documents with respect to Taxes (collectively, “Tax
Returns”) required to be filed by or with respect to Assure have been filed within the prescribed time, with the
appropriate tax authorities and all such Tax Returns are true, correct, and complete in all material respects. No Tax Return
of Assure is being audited by the relevant taxing authority, and there are no outstanding waivers, objections, extensions, or
comparable consents regarding the application of the statute of limitations or period of reassessment with respect to any
Taxes or Tax Returns that have been given or made by Assure (including the time for filing of Tax Returns or paying Taxes)
and Assure has no pending requests for any such waivers, extensions, or comparable consents. Assure has not received a ruling
from any taxing authority or signed an agreement with any taxing authority that could reasonably be expected to have a
Material Adverse Effect on Assure. Assure does not owe any Taxes to the federal government, a provincial government, a
municipal government or any other governmental authority.

 

    

    13

    

 

3.12        Joint
Ventures

 

Assure has not entered into any joint ventures with any third
party.

 

3.13        Restrictive
Covenants

 

Assure is not a party to or bound
or affected by any commitment, agreement or document containing any covenant expressly limiting its freedom to compete in any line
of business, compete in any geographic region, transfer or move any of its assets or operations.

 

3.14        Material
Contracts

 

		(a)	Attached hereto as Schedule 3.14 is a true, complete and accurate list of all
material contracts, agreements and commitments entered into by Assure which are in writing or have been orally agreed to by Assure;
and

 

		(b)	All contracts, agreements, benefit plans, leases and commitments required to
be disclosed to Montreux pursuant to this Section 3.14 are valid, binding and in full force and effect as to Assure, and Assure
is not in breach or violation of, or default under, the terms of any such contract, agreement, plan, lease or commitment, except
where such breach, violation or default would not have a Material Adverse Effect on Assure, and no event has occurred which constitutes
or, with the lapse of time or the giving of notice, or both, would constitute, such a breach, violation or default by Assure.

 

3.15        Necessary
Licenses and Permits

 

Assure and its Subsidiaries have
all necessary and required licenses, permits, consents, concessions and other authorizations of governmental, regulatory or administrative
agencies or authorities, whether foreign, federal, provincial, or local, required to own and lease their respective properties
and assets and to conduct their business as now conducted, except where the failure to hold the foregoing would not have a Material
Adverse Effect on Assure. Neither Assure nor any of its subsidiaries is in default, nor have any of them received any notice of
any claim or default with respect to any such license, permit, consent, concession or authorization. No registrations, filings,
applications, notices, transfers, consents, approvals, audits, qualifications, waivers or other action of any kind is required
by virtue of the execution and delivery of this Agreement, or of the consummation of the transactions contemplated hereby: (a)
to avoid the loss of any license, permit, consent, concession or other authorization or any asset, property or right pursuant to
the terms thereof, or the violation or breach of any law applicable thereto, or (b) to enable Assure to hold and enjoy the same
immediately after the Closing Date in the conduct of its business as conducted prior to the Closing Date.

 

3.16        Compliance
with Law

 

Assure is not in default under, or in
violation of, and has not violated (and failed to cure) any Law including, without limitation, laws relating to the issuance
or sale of securities, privacy and intellectual property, or any licenses, franchises, permits, authorizations or concessions
granted by, or any judgment, decree, writ, injunction or order of, any governmental or regulatory authority, applicable to
its business or any of its properties or assets, except where such default or violation would not have a Material Adverse
Effect on Assure. Assure has not received any notification alleging any violations of any of the foregoing with respect to
which adequate corrective action has not been taken.

 

    

    14

    

 

3.17       Employees

 

Neither Assure nor its Subsidiaries
are subject to any current, pending, threatened, or to the knowledge of Assure, contemplated litigation relating to employment
or termination of employment of its employees and there are no agreements, written or oral, between Assure and any other party
relating to payment relating to a Change of Control in respect of Assure.

 

3.18       Employee
Benefit Plans

 

Assure [REDACTED - confidential information].

 

3.19       Litigation

 

There is no suit, claim, action,
proceeding or, to the knowledge of Assure, investigation pending or threatened against or affecting Assure, or any of its assets
or properties, or any of its assets or properties, or any officer or director thereof in his capacity as an officer or director
thereof.

 

3.20       No
Material Adverse Change

 

Since December 31, 2016, no change has
occurred in the business, operations, results of operations, assets, capitalization or condition (financial or otherwise) of Assure,
whether or not in the ordinary course of business, whether separately or in the aggregate with other occurrences or developments,
and whether insured against or not, which could reasonably be expected to have a Material Adverse Effect on Assure.

 

3.21       Corporate
Documents, Books and Records

 

Complete and correct copies of the Articles,
and of all amendments thereto, of Assure have been previously delivered to Montreux. The minute book of Assure contains complete
and accurate records in all material respects of all meetings and consents in lieu of meetings of the board of directors (and its
committees) and shareholders of Assure since incorporation. Except as reflected in such minute books, there are no minutes of meetings
or consents in lieu of meetings of the board of directors (or its committees) or of the shareholders of Assure.

 

3.22       No
Limitations

 

There is no non-competition, exclusivity
or other similar agreement, commitment or understanding in place, whether written or oral, to which Assure is a party or is otherwise
bound that would now or hereafter, in any way limit the business, use of assets or operations of Assure.

 

3.23       Reporting
Issuer Status

 

Assure is not a “reporting issuer”
(or the equivalent status) in any province or territory of Canada. No order has been issued ceasing or suspending trading or prohibiting
the issue of any securities of Assure and no such proceedings are pending, or to the knowledge of Assure, threatened.

 

    

    15

    

 

3.24       Regulatory
Compliance

 

Assure is in compliance with all regulatory orders, directives
and decisions that have application toAssure except where such non-compliance would not have a Material Adverse Effect on Assure
and Assure has not received notice from any governmental or regulatory authority that Assure is not in compliance with any such
regulatory orders, directives or decisions.

 

3.25       Non-Arm’s
Length Transactions

 

		(a)	Except as disclosed in the Assure Financial Statements, Assure has not made
any payment or loan to, or has borrowed any monies from or is otherwise indebted to, any officer, director, employee, shareholder
or any other Person with whom Assure is not dealing at arm’s length (within the meaning of the Income Tax Act) or any Affiliate
of any of the foregoing; and

 

		(b)	Except as disclosed in this Agreement, Assure is not a party to any contract
or agreement with any officer, director, employee, shareholder or any other Person with whom Assure is not dealing at arm’s
length (within the meaning of the Income Tax Act) or any Affiliate of any of the foregoing.

 

3.26       Enforceability

 

The execution and delivery by Assure
of this Agreement and any other agreement contemplated by this Agreement will result in legally binding obligations of Assure enforceable
against Assure in accordance with the respective terms and provisions hereof and thereof subject, however, to limitations with
respect to enforcement imposed by law in connection with bankruptcy or similar proceedings and to the extent that equitable remedies
such as specific performance and injunction are in the discretion of the court from which they are sought.

 

3.27       Information
Supplied

 

None of the information supplied
or to be supplied by Assure, Assure Neuromonitoring or Assure Networks specifically for inclusion or incorporation by reference
into the Montreux Filing Statement, was, at the date of the Montreux Filing Statement, or at the time of any amendment or supplement
thereof, as amended or supplemented at such date or time, contain any misrepresentation or omit to state a material fact required
to be stated therein or necessary to make the statements therein not misleading in light of the circumstances under which they
are made.

 

ARTICLE 4

REPRESENTATIONS
AND WARRANTIES OF ASSURE

SHAREHOLDERS

 

Each of the Assure Shareholders severally
(and not jointly or jointly and severally) represents and warrants, but only as to himself, herself or itself, to Montreux as follows:

 

4.1         Capacity

 

If an Assure Shareholder is an individual,
such Assure Shareholder has the capacity to own the Assure Shares owned by him or her, and to enter into this Agreement and to
perform his or her obligations under this Agreement. If an Assure Shareholder is not an individual, such Assure Shareholder has
the power and authority to own or hold its Assure Shares, and to enter into this Agreement and to perform its obligations under
this Agreement.

 

    

    16

    

 

4.2         Execution
and Delivery

 

This Agreement and any other agreement
contemplated by this Agreement has been duly executed and delivered by each Assure Shareholder and will result in legally binding
obligations of such Assure Shareholder enforceable against such Assure Shareholder in accordance with the respective terms and
provisions hereof and thereof subject, however, to limitations with respect to enforcement imposed by law in connection with bankruptcy
or similar proceedings and to the extent that equitable remedies such as specific performance and injunction are in the discretion
of the court from which they are sought.

 

4.3         No
Violation

 

The execution and delivery of this Agreement,
the transfer of the Assure Shares, as applicable, and the performance, observance or compliance with the terms of this Agreement
by such Assure Shareholder will not violate, constitute a default under, conflict with, or give rise to any requirement for a waiver
or consent under:

 

		(a)	any provision of law or any order of any court or other governmental agency
applicable to such Assure Shareholder;

 

		(b)	with respect to an Assure Shareholder that is not an individual, the Articles
of such Assure Shareholder;

 

		(c)	any provision of any agreement, instrument or other obligation to which such
Assure Shareholder is a party or by which such Assure Shareholder is bound; or

 

		(d)	any applicable judgment, writ, decree, order or Laws applicable to such Assure Shareholder.

 

4.4         Ownership

 

Each Assure Shareholder is the registered
and beneficial owner of the Assure Shares set out beside his, her or its name in Schedule A, free and clear of any Liens and all
information disclosed in Schedule A with respect to such Assure Shareholder is true and accurate as of the date hereof and will
be true and accurate as of the Closing. Upon the completion of the Closing, except for the rights of Montreux pursuant to this
Agreement with respect to the Assure Shares, there will be no outstanding options, calls or rights of any kind binding on any Assure
Shareholder relating to or providing for the purchase, delivery or transfer of any of his, her or its Assure Shares.

 

ARTICLE 5

REPRESENTATIONS AND WARRANTIES OF MONTREUX

 

In order to induce Assure to enter into
this Agreement and to consummate the transactions contemplated by this Agreement, Montreux hereby represents and warrants as follows
to and in favour of Assure, and acknowledge that the foregoing are relying upon such representations and warranties in connection
with the Share Exchange:

 

5.1         Organization
and Existence

 

Montreux is a corporation duly incorporated,
organized and validly existing under the laws of the province of British Columbia and has the corporate power to own its properties
and to carry on its business as now conducted and has made all necessary filings under all applicable corporate, securities and
taxation laws or any other laws to which Montreux is subject, except where the failure to make such filing would not have a Material
Adverse Effect on Montreux. Montreux does not have any Subsidiaries. No proceedings have been instituted or are pending for the
dissolution or liquidation of Montreux. Other than with respect to the proposed change in Montreux’s corporate name, no
articles of amendment have been or will be filed or authorized by the shareholders of Montreux and no amendments to the Articles
of Montreux have been enacted since Montreux’s incorporation and organization.

 

    

    17

    

 

 

5.2       Authorization

 

		(a)	The execution, delivery and performance by Montreux of this Agreement and the Share Exchange: (i)
are within its corporate power and authority; (ii) have been, or will be duly authorized by all necessary corporate proceedings;
and (iii) do not and will not conflict with or result in any breach of any provision of, or the creation of any Lien upon any of
the property of Montreux pursuant to the Articles of Montreux, any Laws, order, judgment, injunction, license or permit applicable
to Montreux or any indenture, lease, agreement, contract, instrument or Lien, to which Montreux is a party or by which the property
of Montreux may be bound or affected.

 

		(b)	The Montreux Shares, when delivered to the Montreux Shareholders in accordance
with the terms of this Agreement, will be validly issued and outstanding as fully paid and non-assessable Montreux Shares.

 

5.3       Consents

 

The execution, delivery and performance
by Montreux of this Agreement does not and will not require the authorization, approval or consent of, or any filing with, any
governmental authority or agency or any other Person, except those required by applicable securities laws and the rules and policies
of the TSXV.

 

5.4       Authorized
Capital

 

		(a)	The authorized capital of Montreux consists of an unlimited number of Montreux
Shares, of which (prior to the Share Consolidation) 12,409,000 Montreux Shares are issued and outstanding as at the date hereof.
Montreux may issue up to an additional 519,330 Montreux Shares (before accounting for the Share Consolidation) pursuant to the
exercise of existing Montreux Warrants. There are no Montreux Options outstanding. In addition, Montreux may issue additional Montreux
Shares and securities convertible into Montreux Shares pursuant to the Share Exchange and the Financing as contemplated hereunder.

 

		(b)	Following the Share Consolidation and assuming there are no additional exercise
of Montreux Warrants, there will be 4,136,333 Montreux Shares issued and outstanding.

 

		(c)	The Montreux Shares issued and outstanding as at the Closing Time have been, or will at the Closing
Time be, duly authorized and validly issued and outstanding as fully paid and non-assessable shares. None of the Montreux Shares
or Montreux Warrants have been issued in violation of any Laws, the policies of the TSXV, Montreux’s Articles or any agreement
to which Montreux is a party or by which it is bound.

 

5.5       No
Material Adverse Change

 

Since December 31, 2016, except
as disclosed by Montreux on SEDAR, no change has occurred in the business, operations, results of operations, assets, capitalization
or condition (financial or otherwise) of Montreux, whether or not in the ordinary course of business, whether separately or in
the aggregate with other occurrences or developments, and whether insured against or not, which could reasonably be expected to
have a Material Adverse Effect on Montreux.

 

    

    18

    

 

5.6       Reporting
Issuer Status

 

Montreux is a reporting issuer under the
securities legislation of the provinces of British Columbia and Alberta and is not listed as a defaulting issuer under the legislation
or any regulation of any such jurisdiction. No order has been issued ceasing or suspending trading or prohibiting the issue of
the Montreux Shares and no proceedings for such are pending or, to the knowledge of Montreux, threatened; save and except for the
current halt trading of the Montreux Shares pending Closing.

 

5.7       TSXV
Listing

 

The Montreux Shares are listed on the NEX board of the TSXV.

 

5.8       Reports
and Montreux Financial Statements

 

		(a)	Montreux has filed on SEDAR true and complete copies of its audited financial statements for the
period ended December 31, 2016 (the “Montreux Financial Statements”).

 

		(b)	The Montreux Financial Statements were prepared in accordance with IFRS; the balance sheet included
in such Montreux Financial Statements fairly presents the financial condition of Montreux as at the close of business on the date
thereof, and the statement of operations and deficit included in the Montreux Financial Statements fairly presents the results
of operations of Montreux for the fiscal period then ended.

 

		(c)	There were no liabilities, contingent, contractual or otherwise, of Montreux as of December 31,
2016, other than those disclosed in the Montreux Financial Statements and the notes thereto.

 

5.9       Absence
of Certain Changes

 

Since December 31, 2016, Montreux has not (except as
disclosed by Montreux on SEDAR or as disclosed in this Agreement):

 

		(a)	issued, sold, or agreed to issue, sell, pledge, hypothecate, lease, dispose of or encumber any
Montreux Shares or other corporate securities or any right, option or warrant with respect thereto;

 

		(b)	amended or proposed to amend its Articles;

 

		(c)	split, combined or reclassified any of its securities or declared or made any Distribution;

 

		(d)	suffered any material loss relating to litigation or, to the knowledge of Montreux, been threatened
with litigation;

 

		(e)	entered into or amended any employment contracts with any director, officer or senior management
employee, created or amended any employee benefit plan, made any increases in the base compensation, bonuses, paid vacation time
allowed or fringe benefits for its directors or officers other than the adoption of the Montreux Plan;

 

		(f)	suffered damage, destruction or other casualty, loss, or forfeiture of, any property or assets,
whether or not covered by insurance;

 

		(g)	made any capital expenditures, additions or improvements or commitments for the same, except those
which do not exceed $5,000 per month;

 

    

    19

    

 

		(h)	other than in the ordinary course of business: (i) entered into any contract, commitment or agreement
under which it has outstanding Indebtedness for borrowed money or for the deferred purchase price of property; or (ii) made any
loan or advance to any Person;

 

		(i)	acquired or agreed to acquire (by tender offer, exchange offer, merger, amalgamation, acquisition
of shares or assets or otherwise) any Person, corporation, partnership, joint venture or other business organization or division
or acquired or agreed to acquire any material assets;

 

		(j)	entered into any material contracts regarding its business operations, including joint ventures,
partnerships or other arrangements;

 

		(k)	except for the adoption of the Montreux Plan, Montreux has not created any stock option or bonus
plan, paid any bonuses, deferred or otherwise, or deferred any compensation to any of its directors or officers other than such
payments made in the ordinary course of business;

 

		(l)	made any material change in accounting procedures or practices;

 

		(m)	mortgaged, hypothecated or pledged any of the Montreux Assets, or subjected them to any Lien;

 

		(n)	entered into any other material transaction, or any amendment of any contract, lease, agreement
or license which is material to its business;

 

		(o)	sold, leased, subleased, assigned or transferred any of the Montreux Assets;

 

		(p)	cancelled, waived or compromised any debts or claims, including accounts payable to and receivable
from its Affiliates;

 

		(q)	failed to pay or satisfy when due any liability of Montreux where such failure would have a Material
Adverse Effect on Montreux; or

 

		(r)	other than the Share Consolidation, entered into any agreement or understanding to do any of the
foregoing.

 

5.10       Corporate
Documents, Books and Records

 

Complete and correct copies of the Articles
and of all amendments thereto, of Montreux have been previously delivered to Assure. The minute book of Montreux contains complete
and accurate records in all material respects of all meetings and consents in lieu of meetings of the board of directors (and its
committees) and shareholders of Montreux since incorporation. Except as reflected in such minute books, there are no minutes of
meetings or consents in lieu of meetings of the board of directors (or its committees) or of the shareholders of Montreux.

 

5.11       Information

 

All data and information provided by Montreux
at the request of Assure and its agents and representatives, to Assure and its agents and representatives in connection with the
Share Exchange was and is complete and true and correct in all material respects.

 

    

    20

    

 

5.12       No
Other Agreement to Purchase

 

Other than as set out herein
and other than the Montreux Warrants, there are no agreements, options, warrants, rights of conversion or other rights binding
upon or which at any time in the future may become binding upon Montreux to issue any shares or any securities convertible or exchangeable,
directly or indirectly, into any Montreux Shares. There are no shareholders’ agreements, pooling agreements, voting trusts
or other agreements or understandings with respect to the voting of Montreux Shares, or any of them.

 

5.13       Shareholder
Loans

 

There are no loans or other liabilities of Montreux
to any shareholder or to any previous shareholder of Montreux.

 

5.14       Indebtedness
and Liens

 

Other than in the ordinary course
of business or in connection with the transactions contemplated hereby, since December 31, 2016, Montreux has not incurred any:
(i) Indebtedness (other than in connection with this Agreement and the Financing); or (ii) Liens upon any of the Montreux Assets.

 

5.15       Indebtedness
to Officers, Directors and Others

 

Montreux is not indebted to any
director, officer, employee or consultant of Montreux, except for amounts due as normal compensation or reimbursement of ordinary
business expenses and only as permitted pursuant to the CPC Policy.

 

5.16       Taxes

 

All Tax Returns required to be
filed by or with respect to Montreux have been filed within the prescribed time, with the appropriate tax authorities and all such
Tax Returns are true, correct, and complete in all material respects. No Tax Return of Montreux is being audited by the relevant
taxing authority, and there are no outstanding waivers, objections, extensions, or comparable consents regarding the application
of the statute of limitations or period of reassessment with respect to any Taxes or Tax Returns that have been given or made by
Montreux (including the time for filing of Tax Returns or paying Taxes) and Montreux has no pending requests for any such waivers,
extensions, or comparable consents. Montreux has not received a ruling from any taxing authority or signed an agreement with any
taxing authority that could reasonably be expected to have a Material Adverse Effect on Montreux. Montreux does not owe any Taxes
to the federal government, a provincial government, a municipal government or any other governmental authority.

 

5.17       Title
to Assets

 

Montreux has good title to all Montreux Assets, free
of all Liens except for Permitted Liens.

 

5.18       Material
Contracts

 

		(a)	Attached hereto as Schedule 5.18 is a true, complete and accurate list of all
material contracts, agreements and commitments entered into by Montreux which are in writing or have been orally agreed to by Montreux;
and

 

		(b)	All contracts, agreements, benefit plans, leases and commitments required to
be disclosed to Assure pursuant to this Section 5.18 are valid, binding and in full force and effect as to Montreux, and Montreux
is not in breach or violation of, or default under, the terms of any such contract, agreement, plan, lease or commitment,
except where such breach, violation or default would not have a Material Adverse Effect on Montreux, and no event has occurred
which constitutes or, with the lapse of time or the giving of notice, or both, would constitute, such a breach, violation or default
by Montreux.

 

    

    21

    

 

5.19       Title
to Property

 

		(a)	Montreux does not own any real property.

 

		(b)	The Montreux Assets are owned legally and beneficially by Montreux with good
and marketable title thereto, free and clear of all Liens whether contingent or absolute, except as disclosed in the Montreux Financial
Statements or as provided for herein. Montreux is the sole and unconditional owner of, and has good and marketable title to, the
Montreux Assets.

 

5.20       Necessary
Licenses and Permits

 

Montreux has all necessary and
required licenses, permits, consents, concessions and other authorizations of governmental, regulatory or administrative agencies
or authorities, whether foreign, federal, provincial, or local, required to own and lease its properties and assets and to conduct
its business as now conducted, except where the failure to hold the foregoing would not have a Material Adverse Effect on Montreux.
Montreux is not in default, nor has it received any notice of any claim or default with respect to any such license, permit, consent,
concession or authorization. No registrations, filings, applications, notices, transfers, consents, approvals, audits, qualifications,
waivers or other action of any kind is required by virtue of the execution and delivery of this Agreement, or of the consummation
of the transactions contemplated hereby: (a) to avoid the loss of any license, permit, consent, concession or other authorization
or any asset, property or right pursuant to the terms thereof, or the violation or breach of any law applicable thereto, or (b)
to enable Montreux to hold and enjoy the same immediately after the Closing Date in the conduct of its business as conducted prior
to the Closing Date.

 

5.21       Compliance
with Law

 

Montreux is not in default under, or in
violation of, and has not violated (and failed to cure) any Law including, without limitation, laws relating to the issuance or
sale of securities, privacy and intellectual property, or any licenses, franchises, permits, authorizations or concessions granted
by, or any judgment, decree, writ, injunction or order of, any governmental or regulatory authority, applicable to its business
or any of its properties or assets, except where such default or violation would not have a Material Adverse Effect on Montreux.
Montreux has not received any notification alleging any material violations of any of the foregoing with respect to which adequate
corrective action has not been taken.

 

5.22       Employees

 

Montreux does not have any employees
or independent contractors (other than professional advisors engaged by Montreux in connection with the Share Exchange) and there
are no agreements, written or oral, between Montreux and any other party relating to payment, remuneration or compensation for
work performed or services provided (other than professional advisors engaged by Montreux in connection with the Share Exchange)
or payment relating to a Change of Control or other event in respect of Montreux.

 

5.23       Litigation

 

There is no suit, claim, action, proceeding
or, to the knowledge of Montreux, investigation pending or threatened against or affecting Montreux, or any of its assets or properties,
or any officer or director thereof in his capacity as an officer or director thereof.

 

    

    22

    

 

5.24       Employee
Benefit Plans

 

Except for the Montreux Plan, Montreux
does not have any employee benefit plans (or any plan which may be in any way regarded as an employee benefit plan) of any nature
whatsoever nor has it ever had any such plans.

 

5.25       Inventory

 

Montreux does not have (nor has it ever had) any inventory
of any nature whatsoever.

 

5.26       Insurance

 

Montreux does not have (nor has it ever
had) any insurance of any nature whatsoever relating to it or its directors or officers.

 

5.27       No
Limitations

 

There is no non-competition, exclusivity
or other similar agreement, commitment or understanding in place, whether written or oral, to which Montreux is a party or is otherwise
bound that would now or hereafter, in any way limit the business, use of assets or operations of Montreux.

 

5.28       Regulatory
Compliance

 

Montreux is in compliance with all regulatory
orders, directives and decisions that have application to Montreux except where such non-compliance would not have a Material Adverse
Effect on Montreux and Montreux has not received notice from any governmental or regulatory authority that Montreux is not in compliance
with any such regulatory orders, directives or decisions.

 

5.29       Non-Arm’s
Length Transactions

 

		(a)	Montreux has not made any payment or loan to, or has borrowed any monies from or is otherwise indebted
to, any officer, director, employee, shareholder or any other Person with whom Montreux is not dealing at arm’s length (within
the meaning of the Income Tax Act) or any Affiliate of any of the foregoing; and

 

		(b)	Montreux is not a party to any contract or agreement with any officer, director,
employee, shareholder or any other Person with whom Montreux is not dealing at arm’s length (within the meaning of the Income
Tax Act) or any Affiliate of any of the foregoing, other than as disclosed in the Montreux Financial Statements.

 

5.30       Enforceability

 

The execution and delivery by Montreux
of this Agreement and any other agreement contemplated by this Agreement will result in legally binding obligations of Montreux
enforceable against Montreux in accordance with the respective terms and provisions hereof and thereof subject, however, to limitations
with respect to enforcement imposed by law in connection with bankruptcy or similar proceedings and to the extent that equitable
remedies such as specific performance and injunction are in the discretion of the court from which they are sought.

 

    

    23

    

 

5.31       Information
Supplied

 

None of the information supplied
or to be supplied by Montreux specifically for inclusion or incorporation by reference into the Montreux Filing Statement, was,
at the date of the Montreux Filing Statement, or at the time of any amendment or supplement thereof, as amended or supplemented
at such date or time, contain any misrepresentation or omit to state a material fact required to be stated therein or necessary
to make the statements therein not misleading in light of the circumstances under which they are made.

 

ARTICLE 6

COVENANTS

 

6.1       Filings

 

Montreux and Assure shall prepare and file,
or cause to be filed, any filings required under any applicable laws or rules and policies of the TSXV or other regulatory bodies
relating to the Share Exchange. Montreux covenants and agrees to take, in a timely manner, all commercially reasonable actions
and steps necessary in order that effective as at the Closing Date: (i) the Montreux Shares, including for greater certainty, the
Montreux Shares issuable pursuant to the Share Exchange and the conversion of the Subscription Receipts pursuant to the Financing
be listed and posted for trading on the TSXV; (ii) when received, Montreux shall provide Assure with copies of the conditional
and final approval of the TSXV respecting the Share Exchange and the Financing and, the listing and posting for trading of the
additional Montreux Shares; and (iii) the distribution of Montreux Shares to the Assure Shareholders is exempt from the prospectus
and registration requirements of applicable securities laws.

 

6.2       Additional
Agreements

 

Each of the parties hereto agrees
to use its commercially reasonable efforts to take, or cause to be taken, all action and to do, or cause to be done, all things
necessary, proper or advisable to consummate and make effective as promptly as practicable the transactions contemplated by this
Agreement and to cooperate with each other in connection with the foregoing, including using commercially reasonable efforts to:

 

		(a)	obtain all necessary waivers, consents and approvals from other parties to
material agreements, leases and other contracts or agreements;

 

		(b)	obtain all necessary consents, approvals, and authorizations as are required
to be obtained under any federal, provincial or foreign law or regulations;

 

		(c)	defend all lawsuits or other legal proceedings challenging this Agreement or
the consummation of the transactions contemplated hereby;

 

		(d)	cause to be lifted or rescinded any injunction or restraining order or other
remedy adversely affecting the ability of the parties to consummate the transactions contemplated hereby;

 

		(e)	effect all necessary registrations and other filings and submissions of information
requested by governmental authorities;

 

		(f)	comply with all provisions of this Agreement; and

 

		(g)	provide such officers’ certificates as may be reasonably requested by
the other parties hereto in respect of the representations, warranties and covenants of a party hereto.

 

    

    24

    

 

6.3       Access
to Information

 

		(a)	Upon reasonable notice, Assure shall afford to Montreux’s directors,
officers, counsel, accountants and other authorized representatives and advisers complete access (or, where necessary, the provision
of the information requested), during normal business hours and at such other time or times as the parties may reasonably request,
from the date hereof and until the earlier of the Closing Date and the termination of this Agreement, to its properties, books,
contracts and records as well as to management personnel of Assure as Montreux may require or may reasonably request.

 

 

	 	(b)	Upon
reasonable notice, Montreux shall afford to Assure’s directors, officers, counsel, accountants and other authorized representatives
and advisers complete access (or, where necessary, the provision of the information requested), during normal business hours and
at such other time or times as the parties may reasonably request, from the date hereof and until the earlier of the Closing Date
and the termination of this Agreement, to its properties, books, contracts and records as well as to management personnel of Montreux
as Assure may require or may reasonably request.

 

6.4       Conduct
of Business of Assure

 

Assure, Assure Networks and Assure Neuromonitoring
covenants and agrees that, during the period from the date of this Agreement until the earlier of the Closing Date and the date
this Agreement is terminated in accordance with its terms, unless Montreux shall otherwise consent in writing (such consents not
to be unreasonably withheld or delayed), except as required by law or as otherwise expressly permitted or specifically contemplated
by this Agreement:

 

		(a)	Assure shall use all commercially reasonable efforts to maintain and preserve
its business, the Assure Assets and business relationships;

 

		(b)	Assure shall notify Montreux of any Material Adverse Effect on its business; and

 

		(c)	Assure shall not directly or indirectly:

 

		(i)	take any action which may interfere with or be inconsistent with the successful
completion of the transactions contemplated herein or take any action or fail to take any action which may result in a condition
precedent to the transactions described herein not being satisfied;

 

		(ii)	issue, sell, pledge, hypothecate, lease, dispose of or encumber any Assure
Shares or other securities or any right, option or warrant with respect thereto;

 

		(iii)	amend or propose to amend its Articles, except for a change of its name as
agreed to by Montreux and Assure;

 

		(iv)	split, combine or reclassify any of its securities or declare or make any Distribution
or distribute any of its properties or assets to any Person;

 

		(v)	other than in the ordinary course of business, enter into or amend any employment
contracts with any director, officer or senior management employee, create or amend any employee benefit plan, make any increases
in the base compensation, bonuses, paid vacation time allowed or fringe benefits for its directors,
officers, employees or consultants;

 

    

    25

    

 

		(vi)	acquire or agree to acquire (by tender offer, exchange offer, merger, amalgamation, acquisition
of shares or assets or otherwise) any Person, partnership, joint venture or other business organization or division or acquire
or agree to acquire any material assets;

 

		(vii)	create any option or bonus plan, pay any bonuses, deferred or otherwise, or defer any compensation
to any of its directors, officers or employees;

 

		(viii)	make any material change in accounting procedures or practices;

 

		(ix)	mortgage, pledge or hypothecate any of the Assure Assets, or subject them to any Lien, except Permitted
Liens;

 

		(x)	except in the ordinary course of business, enter into any agreement or arrangement granting any
rights to purchase or lease any of the Assure Assets or requiring the consent of any Person to the transfer, assignment or lease
of any of the Assure Assets;

 

		(xi)	except in the ordinary course of business, sell, lease, sublease, assign or transfer (by tender
offer, exchange offer, merger, amalgamation, sale of shares or assets or otherwise) any of the Assure Assets, or cancel, waive
or compromise any debts or claims, including accounts payable to and receivable from Affiliates;

 

		(xii)	enter into any other material transaction or any amendment of any contract, lease, agreement, license
or sublicense which is material to its business;

 

		(xiii)	settle any outstanding claim, dispute, litigation matter, or tax dispute;

 

		(xiv)	transfer any assets to the Assure Shareholders or any of their Subsidiaries or Affiliates or assume
any Indebtedness from the Assure Shareholders or any of their Subsidiaries or Affiliates or enter into any other related party
transactions; or

 

		(xv)	enter into any agreement or understanding to do any of the foregoing.

 

6.5       Conduct
of Business of Montreux

 

Montreux covenants and agrees
that during the period from the date of this Agreement until the earlier of the Closing Date and the date this Agreement is terminated
in accordance with its terms, unless Assure, otherwise consents in writing (such consent not to be unreasonably withheld or delayed):

 

		(a)	the business of Montreux shall be conducted in the ordinary course;

 

		(b)	Montreux shall notify Assure of any Material Adverse Effect on its business;

 

		(c)	Montreux shall at all times comply with all applicable policies of the TSXV, including but not
limited to the CPC Policy, and all applicable securities laws, rules, regulations, policies and instruments;

 

		(d)	Montreux shall not directly or indirectly:

 

    

    26

    

 

		(i)	take any action which may interfere with or be inconsistent with the successful completion of the
transactions contemplated herein or take any action or fail to take any action which may result in a condition precedent to the
transactions described herein not being satisfied;

 

		(ii)	issue, sell, pledge, hypothecate, lease, dispose of or encumber any Montreux Shares or other securities
of Montreux or any right, option or warrant with respect thereto, except for the issuance of Montreux Shares issued pursuant to
the exercise of previously issued Montreux options or warrants;

 

		(iii)	amend or propose to amend its Articles except as contemplated in this Agreement;

 

		(iv)	split, combine or reclassify any of its securities or declare or make any Distribution, or distribute
any of its property or assets to any Person, except for the Share Consolidation;

 

		(v)	enter into or amend any employment contracts with any director, officer or senior management employee,
create or amend any employee benefit plan, make any increases in the base compensation, bonuses, paid vacation time allowed or
fringe benefits for its directors, officers, employees or consultants;

 

		(vi)	other than as contemplated herein, acquire or agree to acquire (by tender offer, exchange offer,
merger, amalgamation, acquisition of shares or assets or otherwise) any Person, partnership, joint venture or other business organization
or division or acquire or agree to acquire any material assets;

 

		(vii)	create any stock option or bonus plan, pay any bonuses, deferred or otherwise, or defer any compensation
to any of its directors or officers;

 

		(viii)	make any material change in accounting procedures or practices;

 

		(ix)	engage in any business that is outside of the business that is being currently conducted by Montreux,
whether as a partner, joint venture participant or otherwise;

 

		(x)	settle any outstanding claim, dispute, litigation matter, or tax dispute; or

 

		(xi)	enter into any agreement or understanding to do any of the foregoing.

 

ARTICLE 7

CONDITIONS TO OBLIGATION TO CLOSE

 

7.1       Montreux’s
Closing Conditions

 

Montreux’s obligation to issue Montreux
Shares in exchange for the Assure Shares on the Closing Date pursuant to Article 2 is subject to compliance by Assure and the Assure
Shareholders with their agreements herein contained and to the satisfaction, on or prior to the Closing Date, of the following
conditions:

 

		(a)	Constating Documents and Certificate of Corporate Existence. Montreux shall
                                                                                                have received from Assure: (i) a copy, certified by one duly authorized officer of Assure to be true and complete as of the
                                                                                                Closing Date, of the Articles of Assure; and (ii) a certificate or the equivalent, dated not more than three days prior to
                                                                                                the Closing Date, of the State of Colorado as to Assure’s corporate good standing.

 

    

    27

    

 

		(b)	TSXV Issuer. Following the Closing of the Share Exchange (concurrently with the Financing),
Montreux satisfying the minimum listing requirements of the TSXV for a Tier 1 or Tier 2 Issuer, as evidenced before Closing by
a conditional listing letter issued by the TSXV.

 

		(c)	Compliance with Sponsorship Requirement. Montreux shall have complied with the sponsorship
requirements set out in TSXV Policy 2.2 Sponsorship and Sponsorship Requirements and shall have engaged a sponsor in accordance
therewith, and the TSXV shall have accepted the sponsor’s report in respect of the Acquisition, or Montreux shall have obtained
an exemption or waiver from the TSXV in respect of compliance with such obligations.

 

		(d)	Required Approvals. Assure shall have obtained the approval of the board of directors
of Assure, of the shareholders of Assure and any other necessary approvals for this Agreement and the Acquisition.

 

		(e)	Proof of Corporate Action. Montreux shall have received from Assure a copy, certified
by a duly authorized officer thereof to be true and complete as of the Closing Date, of the records of all corporate action taken
to authorize the execution, delivery and performance of this Agreement.

 

		(f)	Incumbency Certificates. Montreux shall have received from Assure an incumbency certificate,
dated the Closing Date, signed by a duly authorized officer thereof and giving the name and bearing a specimen signature of each
individual who shall be authorized to sign, in the name and on behalf of respectively, Assure and each Assure Shareholder who is
not an individual, this Agreement and any other ancillary documents.

 

		(g)	Legal Opinion. Montreux shall have received from the counsel of Assure a favourable
opinion covering such matters with respect to the transactions contemplated by this Agreement as Montreux and its counsel may reasonably
request.

 

		(h)	Representations and Warranties. The representations and warranties of Assure contained
herein shall be true and correct in all material respects, on and as of the Closing Date with the same force and effect as if such
representations and warranties were made at such time, and Montreux shall have received on the Closing Date certificates to this
effect, signed by one authorized officer of Assure, and if applicable, Assure shall include with such certificates a description
of each material contract (as described in Section 3.14 herein) entered into by Assure between the date of this Agreement and the
Closing Date and a representation substantially equivalent to Section 3.15(b) in respect of each such material contract, provided
that each such material contract entered into between the date of this Agreement and the Closing Date shall not breach, be in conflict
with or otherwise contravene Section 6.4.

 

		(i)	Covenants. All of the terms, covenants and conditions of this Agreement to be complied
with or performed by Assure at or before the Closing Date shall have been complied with or performed and Montreux shall have received
on the Closing Date certificates to this effect signed by authorized officers of Assure.

 

		(j)	Changes in Directors and Officers; Employment Agreements. At the Closing Time, Montreux
shall enter into employment agreements with the senior executive officers of Assure, containing, among other things, standard non-compete
provisions, such employment agreements to be in form and substance acceptable to Assure and Montreux. Upon completion of the Acquisition,
the board of directors of Montreux will include at least
two directors who shall be independent directors (as defined in section 1.4 of Multilateral Instrument 52-110 Audit Committees).

 

    

    28

    

 

		(k)	Regulatory and Other Consents. There shall have been obtained
from all appropriate federal, provincial, municipal or other governmental or administrative bodies such licences, permits, consents,
approvals, certificates, registrations and authorizations as are required to be obtained by each Assure Shareholder to permit the
transfer of the Assure Shares in each case and the exchange of the Assure Shares for Montreux Shares. Additionally, all required
approvals, consents, authorizations and waivers relating to the consummation of the transactions contemplated by this Agreement
shall have been obtained from the TSXV and the securities regulatory authorities in British Columbia and Alberta, including the
acceptance, by the TSXV of the transactions contemplated in this Agreement and the Acquisition.

 

		(l)	No Action or Proceeding. No bona fide legal or regulatory action
or proceeding shall be pending or threatened by any person to enjoin, restrict or prohibit the exchange by the Assure Shareholders
of the Assure Shares for Montreux Shares or the right of Assure or Montreux from and after the Closing Time to conduct, expand
and develop the business of Assure.

 

		(m)	Execution. Holders of 100% of the outstanding Assure Shares shall have executed this
Agreement.

 

		(n)	Due Diligence. Montreux, and its agents or representatives, shall
have conducted and completed to its satisfaction, acting reasonably, a legal and financial due diligence investigation of Assure.

 

		(o)	No Material Adverse Change. No change shall have occurred in
the business, affairs, financial condition or operations of Assure between the date hereof and the Closing Date which would have
a Material Adverse Effect.

 

		(p)	Financing. Assure shall have completed the Financing.

 

		(q)	TSXV Approval. The TSXV shall have approved the Acquisition and
agreed to list the Montreux Shares issued in connection with this Agreement and the Financing.

 

		(r)	General. All instruments and corporate proceedings in connection
with the transactions contemplated by this agreement (including the Acquisition) shall be satisfactory in form and substance to
Montreux and its counsel, acting reasonably, and Montreux shall have received copies of all documents, including, without limitation,
all documentation required to be delivered to Montreux at or before the Closing Time in accordance with this Agreement, records
of corporate or other proceedings, opinions of counsel and consents which Montreux may have reasonably requested in connection
therewith.

 

The agreements, certificates, documents,
other evidence of compliance and opinions described in this Section 7.1 shall be in form and substance satisfactory to Montreux,
acting reasonably, and shall, except as otherwise provided, be delivered to Montreux at the Closing; provided, however, any one
or more of the foregoing conditions may be waived in writing by Montreux.

 

7.2       Assure’s
Closing Conditions

 

The obligation of Assure to complete
the Acquisition is subject to compliance by Montreux with its agreements herein contained and to the satisfaction, on or before
the Closing Date of the following conditions:

 

    

    29

    

 

		(a)	Constating Documents and Certificate of Corporate Existence. Assure shall have received
from Montreux: (i) a copy, certified by a duly authorized officer of Montreux, to be true and complete as of the Closing Date,
of the Articles of Montreux; (ii) a certificate dated not more than three days prior to the Closing Date, of the government of
British Columbia as to Montreux’s corporate good standing.

 

		(b)	Share Consolidation and Continuance. Montreux shall have
effected the Share Consolidation and shall have affected the continuance into the State of Nevada or equivalent jurisdiction and
shall have delivered to Assure satisfactory evidence of same.

 

		(c)	TSXV Issuer. Following the Closing of the Share Exchange (concurrently
with the Financing), Montreux satisfying the minimum listing requirements of the TSXV for a Tier 1 or Tier 2 Issuer, as evidenced
before Closing by a conditional listing letter issued by the TSXV.

 

		(d)	Compliance with Sponsorship Requirement. Montreux shall have
complied with the sponsorship requirements set out in TSXV Policy 2.2 Sponsorship and Sponsorship Requirements and shall have engaged
a sponsor in accordance therewith, and the TSXV shall have accepted the sponsor’s report in respect of the Acquisition, or
Montreux shall have obtained an exemption or waiver from the TSXV in respect of compliance with such obligations

 

		(e)	Required Approvals. Montreux shall have obtained the approval
of the board of directors of Montreux and of the shareholders of Montreux (if required) and any other necessary approvals for this
Agreement and the Acquisition.

 

		(f)	Due Diligence. Assure, and its agents or representatives, shall
have conducted and completed to its satisfaction, acting reasonably, a legal and financial due diligence investigation of Montreux.

 

		(g)	Proof of Corporate Action. Assure shall have received from Montreux
copies, certified by a duly authorized officer thereof to be true and complete as of the Closing Date, of the records of all corporate
action taken to authorize the execution, delivery and performance of this Agreement.

 

		(h)	Incumbency Certificate. Assure shall have received from Montreux
an incumbency certificate, dated the Closing Date, signed by a duly authorized officer thereof and giving the name and bearing
a specimen signature of each individual who shall be authorized to sign, in the name and on behalf of Montreux, this Agreement
and any other ancillary documents.

 

		(i)	Representations and Warranties. The representations and warranties
of Montreux contained herein shall be true and correct in all material respects on and as of the Closing Date with the same force
and effect, as if such representations and warranties were made at such time, and Assure shall have received on the Closing Date
certificates to this effect signed by one authorized officer of Montreux.

 

		(j)	Covenants. All of the terms, covenants and conditions of this
Agreement to be complied with or performed by Montreux at or before the Closing Date shall have been complied with or performed
and Assure shall have received on the Closing Date certificates to this effect signed by an authorized officer of Montreux.

 

		(k)	Changes in Directors and Officers; Employment Agreements. At
the Closing Time, Montreux shall enter into employment agreements with the senior executive officers of Assure, containing, among
other things, standard non-compete provisions, such employment agreements to be in form and substance acceptable to Assure and
Montreux. Upon completion of the Acquisition, the board of directors of Montreux will include at least
two directors who shall be independent directors (as defined in section 1.4 of Multilateral Instrument 52-110 Audit Committees).

 

    

    30

    

 

		(l)	Regulatory Consents. All required approvals, consents, authorizations and waivers
relating to the consummation of the transactions contemplated by this Agreement shall have been obtained from the TSXV and the
securities regulatory authorities in British Columbia and Alberta, including (i) the issuance of all necessary receipts, approvals,
and acceptances of the Financing; and (ii) the acceptance by the TSXV of the transactions contemplated in this Agreement and the
Acquisition.

 

		(m)	No Action or Proceeding. No bona fide legal or regulatory action or proceeding shall
be pending or threatened by any person to enjoin, restrict or prohibit the exchange by the Assure Shareholders of the Assure Shares
for Montreux Shares.

 

		(n)	TSXV Approval. The TSXV shall have approved this Agreement and the Acquisition and
agreed to list the Montreux Shares issued in connection with this Agreement and the Acquisition and the Montreux Shares to be issued
in connection with the Financing.

 

		(o)	Other Certificates. Assure shall have received: (i) certificates addressed to Assure
and the Assure Shareholders, dated the Closing Date, signed by one executive officer of Montreux in his personal capacity, certifying
that such individual is not aware of any facts or any facts or matters that are inconsistent with the representations and warranties
being given by Montreux pursuant to this Agreement; and (ii) a list of Montreux Assets and liabilities, certified by an executive
officer of Montreux, in form and substance satisfactory to Assure in its sole discretion, acting reasonably.

 

		(p)	General. All instruments and corporate proceedings in connection with the transactions
contemplated by this Agreement shall be satisfactory in form and substance to Assure and its counsel, acting reasonably, and Assure
shall have received copies of all documents as provided for herein, including, without limitation, records of corporate or other
proceedings and consents which Assure may have reasonably requested in connection therewith.

 

The agreements, certificates, documents
and other evidence of compliance described in this Section 7.2 shall be in form and substance satisfactory to Assure, acting reasonably,
and shall, except as otherwise provided, be delivered to Assure at the Closing; provided, however, any one or more of the foregoing
conditions may be waived in writing by Assure.

 

ARTICLE 8

TERMINATION

 

8.1       Termination

 

This Agreement may be terminated by written
notice given by the terminating party to the other party hereto, at any time prior to the Closing:

 

		(a)	by mutual written consent;

 

		(b)	by either Assure or Montreux, if there has been a misrepresentation, breach or non-performance
by the breaching party of any representation, warranty, covenant or obligation contained in this Agreement, which could reasonably
be expected to have a Material Adverse Effect on the terminating party, provided the breaching party has been given notice of and
thirty (30) days to cure any such misrepresentation, breach or non-performance;

 

    

    31

    

 

		(c)	by either Assure or Montreux, if a condition for the terminating party’s benefit has not
been satisfied or waived; or

 

		(d)	by either Assure or Montreux, if the Closing has not occurred on or before the date prior to the
date that is 90 days following the date of this Agreement, or such later date as may be agreed to by Assure and Montreux (provided,
that the right to terminate this Agreement under this Section 8.1(d) shall not be available to any party whose failure to fulfill
any of its obligations under this Agreement has been the cause of or resulted in the failure to consummate the transactions contemplated
hereby by such date).

 

8.2       Effect
of Termination

 

In the event of the termination
of this Agreement as provided in Section 8.1, this Agreement shall forthwith have no further force or effect and there shall be
no obligation on the part of the parties hereunder except with respect to (i) Section 9.1 and Article 11, which will survive such
termination, and (ii) a breach arising from the fraud or wilful misconduct of any party.

 

8.3       Waivers
and Extensions

 

At any time prior to the Closing
Time, each of the parties hereto may (a) extend the time for the performance of any of the obligations or other acts of another
party hereto, (b) waive any inaccuracies in the representations and warranties contained herein or in any document delivered pursuant
hereto or (c) waive compliance with any of the agreements or conditions contained herein. Any such extension or waiver shall be
valid if set forth in an instrument in writing signed by the party to be bound thereby.

 

ARTICLE 9

TRANSACTION COSTS

 

9.1       Transaction
Costs

 

In the event of the termination
of this Agreement pursuant to Section 8.1 hereof, all costs of the Share Exchange incurred by Assure, the Assure Shareholders and
Montreux, as the case may be, in connection with this Agreement, including legal fees, financial advisor fees and all disbursements
by such parties and their advisors shall be borne and paid by the party incurring the costs. Notwithstanding the foregoing, and
for greater certainty, Assure shall be responsible for all costs associated with the Financing as well as all costs associated
with obtaining any necessary regulatory approvals for any of the transactions contemplated hereunder from the applicable securities
commissions and the TSXV.

 

ARTICLE 10

NOTICES

 

10.1       Notices

 

Any demand, notice or communication
to be made or given under or pursuant to this Agreement is to be in writing, except as otherwise expressly permitted or required
under this Agreement, and may be made or given by personal delivery, by registered mail or by transmittal by facsimile machine
or electronic mail addressed to the respective parties as follows:

 

    

    32

    

 

If to Montreux, then to the following address:

 

Suite 545 - 999 Canada Place

Vancouver, British Columbia V6C 3E1

Attention: CEO

Facsimile: 604 684-6242

E-mail: mcgrath@iocorporate.com

 

or at such other address as Montreux shall have specified
by notice actually received by the addressor; with a copy to:

 

Owen Bird Law Corporation

Suite 2900 – 595 Burrard Street,

Vancouver, British Columbia V7X 1J5

Attention: Jeffrey B. Lightfoot

Facsimile: 604-632-4487

E-mail: jlightfoot@owenbird.com

 

If to Assure then to the following address:

 

Assure Holdings, Inc.

10233 S. Parker Road, Suite 105 Parker, CO 80134
USA

Attention: Preston Parsons, Chief Executive Officer
and Director

Email: [REDACTED, privacy of personal information]

 

and, if to the Assure Shareholders, then
to each Assure Shareholder’s respective address listed on the relevant execution page of this Agreement, or at such other
address as Assure or the Assure Shareholders shall have specified by notice actually received by the addressor;

 

with a copy (which shall not constitute notice) to:

 

Minden Gross LLP

145 King Street West, Suite 2200

Toronto, Ontario
M5H 4G2 Attention: Andrew Elbaz

Facsimile: 416-864-9223

E-mail: aelbaz@mindengross.com

 

or to such other mailing or facsimile machine
address as any party may from time notify the others of in accordance with this paragraph. Any demand, notice or communication
made or given by personal delivery is conclusively deemed to have been given on the day of actual delivery thereof, or, if made
or given by registered mail, on the fifth business day following the deposit thereof in the mail or, if made or given by facsimile
transmission, on the first business day following the transmittal thereof and receipt of the appropriate answer back. If the party
making or giving such demand, notice or communication knows or ought reasonably to know, of difficulties with the postal system
which might affect the delivery of mail, any such demand, notice or communication is not to be mailed but is to be made or given
by personal delivery or by facsimile transmission.

 

    

    33

    

 

 

ARTICLE 11

INDEMNIFICATION

 

	11.1	Survival of Covenants, Agreements, Etc.

 

All covenants, agreements, indemnities,
representations and warranties made herein to Montreux or Assure or in any other document referred to herein or delivered to
Montreux or Assure pursuant hereto shall be deemed to have been relied on by Montreux or Assure, as the case may be,
notwithstanding any investigation made by Montreux or Assure and shall survive the execution and delivery of this Agreement
and the deliveries described in Section 2.1; provided that any claim for a breach of the representations and warranties made
by Montreux or Assure is made before (a) the expiration of the later of (i) two years from the Closing Date, and (ii) the
latest date under the applicable Canadian securities laws, or if the applicable Canadian securities laws do not specify such
date, the latest date under the Limitation Act (British Columbia) that such party may be entitled to commence an
action for breach of a representation or warranty under this Agreement, or (b) if applicable, the date this Agreement is
terminated per Section 8.1(c), except for the representations and warranties contained in Sections 3.1 (Organization and
Existence), 3.3 (Authorization), 3.11 (Taxes), 3.27 (Information Supplied), 5.1 (Organization and Existence), 5.2
(Authorization), 5.16 (Taxes) and 5.31 (Information Supplied) which shall survive indefinitely until the expiry of the
applicable limitation period.

 

	11.2	Indemnification by Assure

 

		(a)	Assure agrees to indemnify and save harmless Montreux and its shareholders,
directors, officers, agents and representatives (the “Montreux Indemnified Persons”) from all Losses suffered
or incurred by the Montreux Indemnified Persons as a result of or arising directly or indirectly out of or in connection with:

 

		(i)	any breach by Assure of or any inaccuracy of any representation or warranty
of Assure contained in ARTICLE 3 of this Agreement or in any agreement, certificate or other document delivered pursuant hereto,
provided that Assure shall not be required to indemnify or save harmless the Montreux Indemnified Persons in respect of any breach
or inaccuracy of any representation or warranty unless Montreux shall have provided notice to Assure in accordance with Section
11.4 within six months of the expiration of the applicable time period related to such representation and warranty set out in Section
11.1; and

 

		(ii)	any breach or non-performance by Assure of any covenant to be performed by
them which is contained in this Agreement or in any agreement, certificate or other document delivered pursuant hereto.

 

		(b)	Each Assure Shareholder agrees to severally indemnify and save harmless the
Montreux Indemnified Persons from all Losses suffered or incurred by the Montreux Indemnified Persons as a result of or arising
directly or indirectly out of or in connection with:

 

		(i)	any breach by the Assure Shareholders of or any inaccuracy of any representation
or warranty of the Assure Shareholder contained in ARTICLE 4 of this Agreement or in any agreement, certificate or other document
delivered pursuant thereto, provided that a Assure Shareholder shall not be required to indemnify or save harmless the Montreux
Indemnified Persons in respect of any breach or inaccuracy of any representation or warranty unless Montreux shall have provided
notice to the Assure Shareholder in accordance with Section 11.4 within six months of the expiration of the applicable time period
relating to such representation and warranty set out in Section 11.1; and

 

		(ii)	any failure of such Assure Shareholder to transfer good and valid title to
the Assure Shares to Montreux, free and clear of all Liens, for which a notice of claim under Section 11.4 has been provided to
the Assure Shareholder.

 

    

    34

    

 

	11.3	Indemnification by Montreux

 

Montreux agrees to indemnify
and save harmless Assure and the Assure Shareholders from all Losses suffered or incurred by Assure or the Assure Shareholders
as a result of or arising directly or indirectly out of or in connection with:

 

		(a)	any breach by Montreux of or any inaccuracy of any representation or warranty contained in Article
5 of this Agreement or in any agreement, instrument, certificate or other document delivered pursuant hereto, provided that Montreux
shall not be required to indemnify or save harmless Assure and the Assure Shareholders in respect of any breach or inaccuracy of
any representation or warranty unless Assure or the Assure Shareholders shall have provided notice to Montreux in accordance with
Section 11.4 within six months of the expiration of the applicable time period relating to such representation and warranty set
out in Section 11.1; and

 

		(b)	any breach or non-performance by Montreux of any covenant to be performed by it which is contained
in this Agreement or in any agreement, certificate or other document delivered pursuant hereto.

 

	11.4	Notice of Claim 

 

		(a)	In the event that a party (the “Indemnified Party”) shall become aware of any
claim, proceeding or other matter (a “Claim”) in respect of which another party (the “Indemnifying
Party”) agreed to indemnify the Indemnified Party pursuant to this Agreement, the Indemnified Party shall promptly give
written notice thereof to the Indemnifying Party. Such notice shall specify whether the Claim arises as a result of a claim by
a person against the Indemnified Party (a “Third Party Claim”) or whether the Claim does not so arise (a “Direct
Claim”), and shall also specify with reasonable particularity (to the extent that the information in available) the factual
basis for the Claim and the amount of the Claim, if known.

 

		(b)	If, through the fault of the Indemnified Party, the Indemnifying Party does not receive notice
of any Claim in time to contest effectively the determination of any liability susceptible of being contested, the Indemnifying
Party shall be entitled to set off against the amount claimed by the Indemnified Party the amount of any Losses incurred by the
Indemnifying Party resulting from the Indemnified Party’s failure to give such notice on a timely basis.

 

	11.5	Direct Claims 

 

With respect to any Direct
Claim, following receipt of notice from the Indemnified Party of the Claim, the Indemnifying Party shall have 60 days to make
such investigation of the Claim as is considered necessary or desirable. For the purpose of such investigation, the
Indemnified Party shall make available to the Indemnifying Party the information relied upon by the Indemnified Party to
substantiate the Claim, together with all such other information as the Indemnifying Party may reasonably request. If both
parties agree at or prior to the expiration of such 60-day period (or any mutually agreed upon extension thereof) to the
validity and amount of such Claim, the Indemnifying Party shall immediately pay to the Indemnified Party the full agreed upon
amount of the claim, failing which the matter shall be referred to binding arbitration in such manner as the parties may
agree or shall be determined by a court of competent jurisdiction.

 

    

    35

    

 

	11.6	Third Party Claims

 

With respect to any Third Party
Claim, the Indemnifying Party shall have the right, at its expense, to participate in or assume control of the negotiation, settlement
or defence of the Claim and, in such event, the Indemnifying Party shall reimburse the Indemnified Party for all the Indemnified
Party’s out-of-pocket expenses as a result of such participation or assumption. If the Indemnifying Party elects to assume
such control, the Indemnified Party shall have the right to participate in the negotiation, settlement or defence of such Third
Party Claim and to retain counsel to act on its behalf, provided that the fees and disbursements of such counsel shall be paid
by the Indemnified Party unless the Indemnifying Party consents to the retention of such counsel or unless the named parties to
any action or proceeding include both the Indemnifying Party and the Indemnified Party and the representation of both the Indemnifying
Party and the Indemnified Party by the same counsel would be inappropriate due to the actual or potential differing interests between
them (such as the availability of different defences). If the Indemnifying Party, having elected to assume such control, thereafter
fails to defend the Third Party Claim within a reasonable time, the Indemnified Party shall be entitled to assume such control,
and the Indemnifying Party shall be bound by the results obtained by the Indemnified Party with respect to such Third Party Claim.

 

	11.7	Settlement of Third Party Claims

 

If the Indemnifying Party fails to assume
control of the defence of any Third Party Claim, the Indemnified Party shall have the exclusive right to contest, settle or pay
the amount claimed. Whether or not the Indemnifying Party assumes control of the negotiation, settlement or defence of any Third
Party Claim, the Indemnifying Party shall not settle any Third Party Claim without the written consent of the Indemnified Party,
which consent shall not be unreasonably withheld or delayed; provided, however, that the liability of the Indemnifying Party shall
be limited to the proposed settlement amount if any such consent is not obtained for any reason.

 

	11.8	Co-operation

 

The Indemnified Party and the Indemnifying
Party shall co-operate fully with each other with respect to Third Party Claims, and shall keep each other fully advised with respect
thereto (including supplying copies of all relevant documentation promptly as it become available).

 

	11.9	Exclusivity

 

The provision of this Article 11 shall
apply to any Claim for breach of any covenant, representation, warranty or other provision of this Agreement or any agreement,
certificate or other document delivered pursuant hereto (other than a claim for specific performance or injunctive relief) with
the intent that all such Claims shall be subject to the limitations and other provisions contained in this Article 11.

 

ARTICLE 12

MISCELLANEOUS

 

	12.1	Amendments and Waivers

 

Except as otherwise expressly
provided herein, any term of this Agreement may be amended and the observance of any term of this Agreement may be waived
(either generally or in a particular instance and either retroactively or prospectively) if, but only if, such amendment or
waiver is in writing and is signed, in the case of an amendment, by each of Assure and Montreux, or in the case of a waiver,
by the party against whom the waiver is to be effective. Any amendment or waiver effected in accordance with this Section
12.1 shall be binding upon the Assure Shareholders, Assure and Montreux pursuant to this Agreement.

 

    

    36

    

 

		12.2	Consent to Jurisdiction

 

Each of the Assure Shareholders,
Assure and Montreux hereby agrees to submit to the non-exclusive jurisdiction of the courts in and of the Province of British Columbia
and to the courts to which an appeal of the decisions of such courts may be taken, and consents that service of process with respect
to all courts in and of the Province of British Columbia may be made by registered mail to it at the address set forth in Article
10.

 

		12.3	Governing Law

 

This Agreement shall be governed
by and construed in accordance with the laws of the Province of British Columbia and the federal laws of Canada applicable therein
without giving effect to any choice or conflict of law provision or rule that would cause the application of the domestic substantive
laws of any other jurisdiction, and shall bind and inure to the benefit of the parties hereto and their respective successors and
assigns.

 

		12.4	Further Assurances

 

Assure, the Assure Shareholders and Montreux,
upon the request of any other party hereto, whether before or after the Closing, shall do, execute, acknowledge and deliver or
cause to be done, executed, acknowledged or delivered all such further acts, deeds, documents, assignments, transfers, conveyances,
powers of attorney and assurances as may be reasonably necessary or desirable to effect complete consummation of the Share Exchange
and the Acquisition.

 

		12.5	Time

 

Time is of the essence of this Agreement.

 

		12.6	Assignment

 

This Agreement may not be assigned
by any of the parties hereto without the prior written consent of the other parties hereto, such consents not to be unreasonably
withheld or delayed.

 

		12.7	Public Announcement; Disclosure

 

Assure and the Assure Shareholders
shall not make any public announcement concerning this Agreement or the matters contemplated herein, their discussions or any other
memoranda, letters or agreements between the parties relating to the matters contemplated herein without the prior consent of Montreux,
which consent shall not be unreasonably withheld, and Montreux shall not make any public announcement concerning this Agreement
or the matters contemplated herein, its discussions or any other memoranda, letters or agreements between the parties relating
to the matters contemplated herein without the prior consent of Assure, which consent shall not be unreasonably withheld, provided
that no party shall be prevented from making any disclosure which is required to be made by law or any rules of a stock exchange
or similar organization to which it is bound.

 

    

    37

    

 

		12.8	Entire Agreement, Counterparts, Section Headings

 

This Agreement, and the Schedules hereto,
sets forth the entire understanding of the parties hereto with respect to the transactions contemplated hereby and supersedes any
prior written or oral understandings with respect thereto. This Agreement may be executed by facsimile or electronic mail and in
one or more counterparts thereof, each of which shall be deemed an original but all of which together shall constitute one and
the same instrument. The headings in this Agreement are for convenience of reference only and shall not alter or otherwise affect
the meaning hereof.

 

		12.9	Regulatory Approval

 

This Agreement is subject to regulatory approval, including,
without limitation, that of the TSXV.

 

[REMAINDER OF PAGE LEFT BLANK INTENTIONALLY]

 

    

    38

    

 

IN WITNESS WHEREOF,
the parties hereto have executed this Agreement as of the date first above written.

 

	 	MONTREUX
    CAPITAL CORP.
	 	 
	 	Per:	 (signed)
	 	 	Authorized Signing Officer
	 	 
	 	ASSURE
    HOLDINGS INC.
	 	 
	 	Per:	 (signed)
	 	 	Authorized Signing Officer

 

    

     

    

 

Counterpart Execution Page for Assure Shareholders

 

This
page constitutes the counterpart execution page of this Agreement dated as of the 16th
day of May, 2017 among Montreux, Assure and the shareholders of Assure and, upon execution hereof, the undersigned
is bound by and is a party to this Agreement as an Assure Shareholder.

 

[All names and personal information REDACTED for privacy
purposes]

 

	 	 	Name of Assure Shareholder (please print)
	 
	Registration Instructions:	 	By:	(signed)
	 	 	 	Authorized Signatory
	 	 	 	 
	Register the Montreux Shares issuable to the Assure Shareholder in the name and at the address of the Assure Shareholder set forth
herein or as follows:	 	Official Capacity or title (please print)
	 	 	Address of Assure Shareholder
	 	 	 
	Name for Registration Purposes	 	 
	 	 	 
	 	 	 
	 	 	 
	 	 	 
	 	 	 
	 	 	 
	Address for Registration Purposes	 	Please print name of individual whose signature appears above if different than the name of the Assure Shareholder printed above.
	 	 	 
	 	 	
	 	 	 
	 	 	Assure Shareholder’s Telephone Number
	 	 	 
	 	 	 
	 	 	Assure Shareholder’s Facsimile Number
	 	 	 
	Note: Montreux Shares may only be registered in a name other than
    the Assure Shareholder with the approval of Montreux and Assure	 	Assure Shareholder’s E-mail Address
	 	 	 
	 	 	Social Insurance Number or Corporate Tax Identification Number
	 	 	 
	 	 	Number of Assure Shares held or to be held by the Assure Shareholder

 

    

     

    

 

SCHEDULE A

 

ASSURE

 

SHAREHOLDERS

 

	Name of Shareholders	 	Shares	 	 	Ownership Percentage	 
	Preston Parsons	 	 	20,664,933	 	 	 	86.10	%
	 	 	 	 	 	 	 	 	 
	Matthew Willer	 	 	2,296,104	 	 	 	9.57	%
	 	 	 	 	 	 	 	 	 
	Urs Kuederli	 	 	432,901	 	 	 	1.80	%
	 	 	 	 	 	 	 	 	 
	Alex Rasmussen	 	 	432,901	 	 	 	1.80	%
	 	 	 	 	 	 	 	 	 
	Kathleen Parsons	 	 	173,161	 	 	 	0.72	%
	 	 	 	 	 	 	 	 	 
	TOTAL	 	 	24,000,000	 	 	 	100	%

 

    

     

    

 

Schedule B

 

Assure Options

 

	Registration	 	Amount	 	 	Date Issued	 	Exercise Price	 	Expiry Time
	Preston Parsons	 	 	2,500,000	 	 	August 25, 2015	 	USD$0.05	 	August 25, 2025
	 	 	 	 	 	 		 	 	 	
	Matthew Willer	 	 	500,000	 	 	August 25, 2015	 	USD$0.05	 	August 25, 2025
	 	 	 	 	 	 		 	 	 	
	Sequoia Capital Partners Inc.	 	 	150,000	 	 	March 2, 2017	 	C$0.50	 	March 2, 2022
	Martin Burian	 	 	25,000	 	 	May 11, 2017	 	C$0.50	 	May 11, 2022
	John Farlinger	 	 	25,000	 	 	May 11, 2017	 	C$0.50	 	May 11, 2022
	TOTAL	 	 	3,200,000	 	 	 	 	 	 	 

 

Assure Performance Shares

 

	Registration	 	Amount	 	 	Date Issued
	Preston Parsons	 	 	5,000,000	 	 	July 15, 2016
	Matthew Willer	 	 	1,000,000	 	 	July 15, 2016
	TOTAL	 	 	6,000,000	 	 	 

 

On July 15, 2016, Assure Neuromonitoring reserved an
additional 6,000,000 Assure Shares

 

(the “Assure Performance
Shares”), with the approval of Montreux. Pursuant to stock grant agreements dated July 15, 2016 (the “Stock
Grant Agreements”), 5,000,000 shares of Assure Neuromonitoring are to be issued to Mr. Parsons and 1,000,000 shares of
Assure Neuromonitoring are to be issued to Mr. Willer if the Resulting Issuer achieves C$7,500,000 in EBITDA prior to the end of
December 31, 2017 (the “Threshold EBITDA”). The Threshold EBITDA will be determined by the results of the audited
consolidated financial statements of the Resulting Issuer. Should the Threshold EBITDA be achieved, Mr. Parsons will be awarded
5,000,000 Resulting Issuer Shares and Mr. Willer will be awarded 1,000,000 Resulting Issuer Shares on May 1, 2018.

 

Assure Broker Warrants

 

[List REDACTED for confidentiality purposes]

 

    

     

    

 

SCHEDULE 3.14

 

ASSURE MATERIAL

CONTRACTS

 

[List REDACTED for confidentiality purposes]

 

    

     

    

 

SCHEDULE 5.18

 

MONTREUX MATERIAL CONTRACTS

 

		1.	Transfer Agency and Registrarship Agreement, dated October 31, 2007 between Montreux and Olympia
Trust Company (as it then was).

 

		2.	CPC Escrow Agreement dated November 7, 2007 among Montreux, Olympia Trust Company
(as it then was) and certain shareholders of Montreux.

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00318-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00318-of-00352.parquet"}]]